SMMLCK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00264 | S54 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LLGLCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFt |
| O14950 | S20 | EPSD|PSP | MYL12B MRLC2 MYLC2B | _MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| O14950 | T19 | EPSD|PSP | MYL12B MRLC2 MYLC2B | __MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P10916 | S15 | EPSD|PSP | MYL2 MLC2 | ______MAPKKAKKRAGGANsNVFsMFEQTQIQEFKEAFTI |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P19105 | T18 | EPSD | MYL12A MLCB MRLC3 RLC | ___MSSKRTKTKTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P24844 | S20 | SIGNOR|EPSD|PSP | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P24844 | T19 | SIGNOR|EPSD|PSP | MYL9 MLC2 MRLC1 MYRL2 | __MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| Q05682 | S744 | SIGNOR | CALD1 CAD CDM | sPtAAGtPNKEtAGLKVGVSsRINEWLTKtPDGNKsPAPKP |
| Q12913 | S843 | Sugiyama | PTPRJ DEP1 | PNITSVSHNSVKVKFSGFEAsHGPIKAYAVILTTGEAGHPS |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15746 | S1438 | Sugiyama | MYLK MLCK MLCK1 MYLK1 | ESELTTVGEKPEEPKDEVEVsDDDEKEPEVDyRTVTINTEQ |
| Q15746 | S1570 | Sugiyama | MYLK MLCK MLCK1 MYLK1 | IIDEDFELTERECIKYMRQIsEGVEyIHKQGIVHLDLKPEN |
| Q32MK0 | S275 | Sugiyama | MYLK3 MLCK | SENLRTGLELAPAPGRVNVVsPSLEVAPGAGQGASSSRPDP |
| Q32MK0 | S401 | Sugiyama | MYLK3 MLCK | CLQAPGTEPGEQtPEGARELsPLQESSsPGGVKAEEEQRAG |
| Q32MK0 | S408 | Sugiyama | MYLK3 MLCK | EPGEQtPEGARELsPLQESSsPGGVKAEEEQRAGAEPGtRP |
| Q32MK0 | S429 | Sugiyama | MYLK3 MLCK | PGGVKAEEEQRAGAEPGtRPsLARSDDNDHEVGALGLQQGK |
| Q32MK0 | T359 | Sugiyama | MYLK3 MLCK | IQEMDTPGEMLMTGRGSLGPtLtTEAPAAAQPGKQGPPGTG |
| Q32MK0 | T361 | Sugiyama | MYLK3 MLCK | EMDTPGEMLMTGRGSLGPtLtTEAPAAAQPGKQGPPGTGRC |
| Q32MK0 | T393 | Sugiyama | MYLK3 MLCK | QGPPGTGRCLQAPGTEPGEQtPEGARELsPLQESSsPGGVK |
| Q32MK0 | T426 | Sugiyama | MYLK3 MLCK | SSsPGGVKAEEEQRAGAEPGtRPsLARSDDNDHEVGALGLQ |
| Q32MK0 | T807 | Sugiyama | MYLK3 MLCK | QLLLQKYIAQRKWKKHFyVVtAANRLRKFPTSP________ |
| Q32MK0 | Y804 | Sugiyama | MYLK3 MLCK | LKSQLLLQKYIAQRKWKKHFyVVtAANRLRKFPTSP_____ |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9H6T0 | Y326 | Sugiyama | ESRP2 RBM35B PP7059 | VDSEQRDLALQRHKHHMGVRyIEVYKATGEEFVKIAGGTSL |
| Q9NSY1 | S1029 | Sugiyama | BMP2K BIKE HRIHFB2017 | KPTYRtPERARRHKKVGRRDsQssNEFLTIsDSKENISVAL |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Meiotic synapsis | R-HSA-1221632 | 6.005592e-10 | 9.221 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.119955e-08 | 7.951 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.727943e-08 | 7.762 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.900439e-08 | 7.310 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.340809e-07 | 6.873 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.707270e-07 | 6.768 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.613623e-07 | 6.792 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.320350e-07 | 6.634 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.164916e-07 | 6.380 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.975988e-07 | 6.303 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.107984e-07 | 6.292 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.411848e-07 | 6.130 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.093434e-07 | 6.092 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.036518e-06 | 5.984 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.113167e-06 | 5.953 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.172604e-06 | 5.931 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.612236e-06 | 5.793 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.597813e-06 | 5.796 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.612236e-06 | 5.793 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.709967e-06 | 5.567 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.284135e-06 | 5.484 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.175829e-06 | 5.498 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.288551e-06 | 5.483 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.049757e-06 | 5.393 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.049757e-06 | 5.393 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.117663e-06 | 5.385 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.126291e-06 | 5.213 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.809356e-06 | 5.107 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.731047e-06 | 5.059 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.163718e-05 | 4.934 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.165386e-05 | 4.934 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.165386e-05 | 4.934 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.205011e-05 | 4.919 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.439459e-05 | 4.842 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.500686e-05 | 4.824 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.848401e-05 | 4.733 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.816879e-05 | 4.741 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.354941e-05 | 4.628 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.471854e-05 | 4.459 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.866451e-05 | 4.413 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.866451e-05 | 4.413 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.866451e-05 | 4.413 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.565615e-05 | 4.341 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.871429e-05 | 4.163 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.009657e-05 | 4.045 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.044082e-04 | 3.981 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.208654e-04 | 3.918 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.295740e-04 | 3.887 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.437466e-04 | 3.842 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.563121e-04 | 3.806 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.617121e-04 | 3.791 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.596376e-04 | 3.797 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.792135e-04 | 3.747 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.820411e-04 | 3.740 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.910230e-04 | 3.719 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.946468e-04 | 3.711 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.126357e-04 | 3.672 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.394747e-04 | 3.621 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.427448e-04 | 3.615 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.822714e-04 | 3.549 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.163161e-04 | 3.500 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.247020e-04 | 3.489 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.247020e-04 | 3.489 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.210117e-04 | 3.493 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.358185e-04 | 3.474 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.568075e-04 | 3.448 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.589500e-04 | 3.338 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.698305e-04 | 3.328 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.987653e-04 | 3.302 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.767124e-04 | 3.322 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.812808e-04 | 3.167 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.814145e-04 | 3.167 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.337556e-04 | 3.134 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.436679e-04 | 3.129 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.723053e-04 | 3.059 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.174190e-04 | 3.037 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.051505e-03 | 2.978 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.403401e-03 | 2.853 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.408639e-03 | 2.851 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.427528e-03 | 2.845 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.575030e-03 | 2.803 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.710972e-03 | 2.767 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.657018e-03 | 2.781 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.683756e-03 | 2.774 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.743630e-03 | 2.759 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.807195e-03 | 2.743 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.899920e-03 | 2.721 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.067163e-03 | 2.685 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.462278e-03 | 2.609 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.462278e-03 | 2.609 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.562400e-03 | 2.591 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.593638e-03 | 2.586 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.706437e-03 | 2.568 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.969761e-03 | 2.527 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.176729e-03 | 2.498 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.217946e-03 | 2.492 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.217946e-03 | 2.492 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.562335e-03 | 2.448 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.562335e-03 | 2.448 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.562335e-03 | 2.448 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.516108e-03 | 2.454 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.664253e-03 | 2.436 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.395204e-03 | 2.357 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.395204e-03 | 2.357 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.581907e-03 | 2.339 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.805481e-03 | 2.318 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.925864e-03 | 2.308 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.102408e-03 | 2.292 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.169067e-03 | 2.287 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.193335e-03 | 2.285 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.899857e-03 | 2.229 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.401862e-03 | 2.194 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.520253e-03 | 2.186 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.627552e-03 | 2.179 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.613118e-03 | 2.118 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.829887e-03 | 2.106 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 7.847939e-03 | 2.105 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.159999e-03 | 2.088 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.687096e-03 | 2.061 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.955250e-03 | 2.048 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.132166e-03 | 2.039 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.370892e-03 | 2.028 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.012397e-02 | 1.995 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.040081e-02 | 1.983 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.051637e-02 | 1.978 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.073203e-02 | 1.969 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.131247e-02 | 1.946 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.142917e-02 | 1.942 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.150703e-02 | 1.939 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.202080e-02 | 1.920 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.374818e-02 | 1.862 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.274051e-02 | 1.895 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.295117e-02 | 1.888 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.373156e-02 | 1.862 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.295117e-02 | 1.888 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.340560e-02 | 1.873 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.245833e-02 | 1.905 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.425145e-02 | 1.846 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.466093e-02 | 1.834 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.605427e-02 | 1.794 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.741949e-02 | 1.759 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.741949e-02 | 1.759 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.772311e-02 | 1.751 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.778540e-02 | 1.750 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.799012e-02 | 1.745 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.827899e-02 | 1.738 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.827899e-02 | 1.738 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.874901e-02 | 1.727 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.874901e-02 | 1.727 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.069787e-02 | 1.684 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.100361e-02 | 1.678 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.011115e-02 | 1.697 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.912513e-02 | 1.718 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.149015e-02 | 1.668 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.149477e-02 | 1.668 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.218173e-02 | 1.654 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.237941e-02 | 1.650 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.249724e-02 | 1.648 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.273838e-02 | 1.643 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.290589e-02 | 1.640 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.331659e-02 | 1.632 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.395510e-02 | 1.621 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.445014e-02 | 1.612 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.521605e-02 | 1.598 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.537545e-02 | 1.596 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.542993e-02 | 1.595 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.545405e-02 | 1.594 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.634652e-02 | 1.579 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.924245e-02 | 1.534 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.924245e-02 | 1.534 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.802666e-02 | 1.552 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.634652e-02 | 1.579 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.924245e-02 | 1.534 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.858987e-02 | 1.544 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.809124e-02 | 1.551 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.614022e-02 | 1.583 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.944015e-02 | 1.531 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.040849e-02 | 1.517 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.132066e-02 | 1.504 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.228227e-02 | 1.491 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.307597e-02 | 1.480 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.415408e-02 | 1.467 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.588288e-02 | 1.445 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.588288e-02 | 1.445 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.672946e-02 | 1.435 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.672946e-02 | 1.435 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.672946e-02 | 1.435 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.672946e-02 | 1.435 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.765019e-02 | 1.424 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.783204e-02 | 1.422 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.936470e-02 | 1.405 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.016255e-02 | 1.396 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.016255e-02 | 1.396 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.033898e-02 | 1.394 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.771875e-02 | 1.321 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.771875e-02 | 1.321 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.703027e-02 | 1.328 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.747316e-02 | 1.324 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.759710e-02 | 1.322 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.771875e-02 | 1.321 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.771875e-02 | 1.321 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.797057e-02 | 1.319 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.823299e-02 | 1.317 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.840591e-02 | 1.315 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.840591e-02 | 1.315 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.840591e-02 | 1.315 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.933774e-02 | 1.307 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.172716e-02 | 1.286 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.303020e-02 | 1.275 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.443511e-02 | 1.264 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.572603e-02 | 1.254 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.730333e-02 | 1.242 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.963054e-02 | 1.225 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.989522e-02 | 1.223 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.122578e-02 | 1.213 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.132537e-02 | 1.212 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.238644e-02 | 1.205 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.304471e-02 | 1.200 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.078785e-02 | 1.150 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.245478e-02 | 1.140 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.078785e-02 | 1.150 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.803385e-02 | 1.108 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.134587e-02 | 1.147 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.324326e-02 | 1.135 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.852402e-02 | 1.164 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.852402e-02 | 1.164 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.772156e-02 | 1.169 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.152071e-02 | 1.146 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.627867e-02 | 1.118 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.078785e-02 | 1.150 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.554584e-02 | 1.183 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.134587e-02 | 1.147 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.078785e-02 | 1.150 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.661805e-02 | 1.176 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.807426e-02 | 1.107 | 1 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.969652e-02 | 1.099 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 7.969652e-02 | 1.099 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.972719e-02 | 1.098 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.205528e-02 | 1.086 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.273645e-02 | 1.082 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.275025e-02 | 1.082 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.492654e-02 | 1.023 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 9.492654e-02 | 1.023 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 9.492654e-02 | 1.023 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.975219e-02 | 1.047 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.975219e-02 | 1.047 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 8.975219e-02 | 1.047 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.052131e-01 | 0.978 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.052131e-01 | 0.978 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.052131e-01 | 0.978 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.052131e-01 | 0.978 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.906456e-02 | 1.050 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.906456e-02 | 1.050 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.886881e-02 | 1.005 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.987490e-02 | 1.001 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.865226e-02 | 1.052 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.781127e-02 | 1.056 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.004397e-01 | 0.998 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.152669e-02 | 1.038 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.476700e-02 | 1.023 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.039489e-01 | 0.983 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.039489e-01 | 0.983 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.052131e-01 | 0.978 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.010909e-01 | 0.995 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.812173e-02 | 1.055 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.152669e-02 | 1.038 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 8.975219e-02 | 1.047 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.627094e-02 | 1.017 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.076199e-01 | 0.968 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.906456e-02 | 1.050 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.476700e-02 | 1.023 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.608791e-02 | 1.017 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.022094e-01 | 0.991 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.028797e-01 | 0.988 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.975219e-02 | 1.047 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.052131e-01 | 0.978 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.058506e-01 | 0.975 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.790064e-02 | 1.009 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.067879e-01 | 0.971 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.077213e-01 | 0.968 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.077213e-01 | 0.968 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.090852e-01 | 0.962 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.090852e-01 | 0.962 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.142711e-01 | 0.942 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.143497e-01 | 0.942 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.147204e-01 | 0.940 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.196266e-01 | 0.922 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.196890e-01 | 0.922 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.213248e-01 | 0.916 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.213248e-01 | 0.916 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.226274e-01 | 0.911 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.240953e-01 | 0.906 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.245465e-01 | 0.905 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.278840e-01 | 0.893 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.283925e-01 | 0.891 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.306551e-01 | 0.884 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.306551e-01 | 0.884 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.306551e-01 | 0.884 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.389592e-01 | 0.857 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.389592e-01 | 0.857 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 1.389592e-01 | 0.857 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.389592e-01 | 0.857 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.389592e-01 | 0.857 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.389592e-01 | 0.857 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.389592e-01 | 0.857 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.389592e-01 | 0.857 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.808522e-01 | 0.743 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.808522e-01 | 0.743 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 1.808522e-01 | 0.743 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.808522e-01 | 0.743 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.808522e-01 | 0.743 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.808522e-01 | 0.743 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.808522e-01 | 0.743 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.808522e-01 | 0.743 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.808522e-01 | 0.743 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.808522e-01 | 0.743 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 1.808522e-01 | 0.743 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.207093e-01 | 0.656 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 2.207093e-01 | 0.656 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.207093e-01 | 0.656 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.586294e-01 | 0.587 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.586294e-01 | 0.587 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.586294e-01 | 0.587 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.586294e-01 | 0.587 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.586294e-01 | 0.587 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.586294e-01 | 0.587 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.379876e-01 | 0.860 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.379876e-01 | 0.860 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.379876e-01 | 0.860 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.947065e-01 | 0.531 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.947065e-01 | 0.531 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.947065e-01 | 0.531 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.947065e-01 | 0.531 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.947065e-01 | 0.531 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.947065e-01 | 0.531 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.947065e-01 | 0.531 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.726076e-01 | 0.763 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.726076e-01 | 0.763 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.904040e-01 | 0.720 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.290301e-01 | 0.483 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.290301e-01 | 0.483 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.290301e-01 | 0.483 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.290301e-01 | 0.483 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.290301e-01 | 0.483 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.290301e-01 | 0.483 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.290301e-01 | 0.483 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.290301e-01 | 0.483 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.290301e-01 | 0.483 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.290301e-01 | 0.483 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.084287e-01 | 0.681 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.419581e-01 | 0.848 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.266174e-01 | 0.645 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.616853e-01 | 0.442 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.616853e-01 | 0.442 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.616853e-01 | 0.442 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.616853e-01 | 0.442 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.616853e-01 | 0.442 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.616853e-01 | 0.442 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.449116e-01 | 0.611 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.449116e-01 | 0.611 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.632581e-01 | 0.580 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.927531e-01 | 0.406 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.927531e-01 | 0.406 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.927531e-01 | 0.406 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.927531e-01 | 0.406 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.927531e-01 | 0.406 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.927531e-01 | 0.406 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.927531e-01 | 0.406 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.816086e-01 | 0.550 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.816086e-01 | 0.550 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.283934e-01 | 0.641 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.283934e-01 | 0.641 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.999193e-01 | 0.523 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.223105e-01 | 0.374 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.223105e-01 | 0.374 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.342292e-01 | 0.872 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.181507e-01 | 0.497 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.547134e-01 | 0.594 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.680306e-01 | 0.572 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.362673e-01 | 0.473 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.362673e-01 | 0.473 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.504310e-01 | 0.346 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.504310e-01 | 0.346 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.504310e-01 | 0.346 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.504310e-01 | 0.346 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.504310e-01 | 0.346 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.302290e-01 | 0.638 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.899306e-01 | 0.721 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.668714e-01 | 0.778 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.623452e-01 | 0.581 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.083662e-01 | 0.511 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.083662e-01 | 0.511 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.720314e-01 | 0.429 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.720314e-01 | 0.429 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.218761e-01 | 0.492 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.446708e-01 | 0.611 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.446708e-01 | 0.611 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.842049e-01 | 0.546 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.896250e-01 | 0.409 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.069951e-01 | 0.390 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.069951e-01 | 0.390 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.026367e-01 | 0.299 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.026367e-01 | 0.299 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.026367e-01 | 0.299 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.026367e-01 | 0.299 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.026367e-01 | 0.299 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.623568e-01 | 0.441 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.286011e-01 | 0.483 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.241220e-01 | 0.373 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.011180e-01 | 0.521 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.509697e-01 | 0.455 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.509697e-01 | 0.455 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.409881e-01 | 0.356 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.268514e-01 | 0.278 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.268514e-01 | 0.278 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.268514e-01 | 0.278 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.300877e-01 | 0.481 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.621621e-01 | 0.441 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.621621e-01 | 0.441 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.024433e-01 | 0.395 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.156543e-01 | 0.381 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.845171e-01 | 0.415 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.956622e-01 | 0.403 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.350738e-01 | 0.475 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.788370e-01 | 0.422 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.983513e-01 | 0.400 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.055720e-01 | 0.296 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.055720e-01 | 0.296 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.274909e-01 | 0.369 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.209462e-01 | 0.283 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.209462e-01 | 0.283 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.209462e-01 | 0.283 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.925554e-01 | 0.308 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.925554e-01 | 0.308 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.048933e-01 | 0.297 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.170742e-01 | 0.286 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.041150e-01 | 0.297 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.419201e-01 | 0.616 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.154340e-01 | 0.667 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.542370e-01 | 0.451 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.414939e-01 | 0.617 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.542370e-01 | 0.451 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.154340e-01 | 0.667 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.927531e-01 | 0.406 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.814249e-01 | 0.551 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.956622e-01 | 0.403 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.898805e-01 | 0.310 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.288699e-01 | 0.368 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.379876e-01 | 0.860 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.084287e-01 | 0.681 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.771842e-01 | 0.321 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.771842e-01 | 0.321 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.268514e-01 | 0.278 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.417783e-01 | 0.355 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.880237e-01 | 0.541 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.379876e-01 | 0.860 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.771842e-01 | 0.321 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.816086e-01 | 0.550 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.948765e-01 | 0.530 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.449116e-01 | 0.611 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.449116e-01 | 0.611 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.507744e-01 | 0.822 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.816086e-01 | 0.550 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.223105e-01 | 0.374 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.223105e-01 | 0.374 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.342292e-01 | 0.872 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.814249e-01 | 0.551 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.509697e-01 | 0.455 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.948765e-01 | 0.530 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.048933e-01 | 0.297 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.048933e-01 | 0.297 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.048933e-01 | 0.297 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.024433e-01 | 0.395 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.830767e-01 | 0.737 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.496130e-01 | 0.825 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.864415e-01 | 0.729 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.551098e-01 | 0.809 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.904040e-01 | 0.720 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.328301e-01 | 0.877 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 3.927531e-01 | 0.406 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.026386e-01 | 0.693 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.999193e-01 | 0.523 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.547134e-01 | 0.594 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.094025e-01 | 0.679 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.265073e-01 | 0.645 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.203945e-01 | 0.494 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.575783e-01 | 0.340 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.026367e-01 | 0.299 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.114502e-01 | 0.386 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.948765e-01 | 0.530 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.212661e-01 | 0.493 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.586294e-01 | 0.587 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.947065e-01 | 0.531 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.290301e-01 | 0.483 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.449116e-01 | 0.611 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.999193e-01 | 0.523 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 4.771842e-01 | 0.321 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.206405e-01 | 0.656 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.891483e-01 | 0.410 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.268514e-01 | 0.278 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.800672e-01 | 0.319 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.800672e-01 | 0.319 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.209462e-01 | 0.283 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.128093e-01 | 0.672 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.616853e-01 | 0.442 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.218761e-01 | 0.492 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.519623e-01 | 0.818 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.488875e-01 | 0.457 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.209462e-01 | 0.283 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.283934e-01 | 0.641 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.362673e-01 | 0.473 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.048933e-01 | 0.297 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.864415e-01 | 0.729 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.206405e-01 | 0.656 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.541266e-01 | 0.812 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.680306e-01 | 0.572 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.156543e-01 | 0.381 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 4.898805e-01 | 0.310 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.948765e-01 | 0.530 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.151315e-01 | 0.288 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.672073e-01 | 0.330 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 1.808522e-01 | 0.743 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.586294e-01 | 0.587 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.586294e-01 | 0.587 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.551098e-01 | 0.809 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.947065e-01 | 0.531 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.290301e-01 | 0.483 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.290301e-01 | 0.483 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.084287e-01 | 0.681 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.084287e-01 | 0.681 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.927531e-01 | 0.406 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.283934e-01 | 0.641 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.223105e-01 | 0.374 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.666455e-01 | 0.778 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.504310e-01 | 0.346 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.771842e-01 | 0.321 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.771842e-01 | 0.321 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.026367e-01 | 0.299 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.268514e-01 | 0.278 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.268514e-01 | 0.278 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.268514e-01 | 0.278 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.268514e-01 | 0.278 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.167644e-01 | 0.380 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.615801e-01 | 0.336 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.830753e-01 | 0.417 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.328301e-01 | 0.877 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.915484e-01 | 0.535 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.610341e-01 | 0.793 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.154340e-01 | 0.667 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.265073e-01 | 0.645 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.900304e-01 | 0.721 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.927531e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.285661e-01 | 0.641 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.379876e-01 | 0.860 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.156543e-01 | 0.381 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.156543e-01 | 0.381 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.898805e-01 | 0.310 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.859462e-01 | 0.313 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.695800e-01 | 0.771 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.508345e-01 | 0.821 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.328301e-01 | 0.877 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.119181e-01 | 0.506 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.467662e-01 | 0.350 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.224006e-01 | 0.492 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.248200e-01 | 0.280 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.248200e-01 | 0.280 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.904040e-01 | 0.720 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.290301e-01 | 0.483 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.927531e-01 | 0.406 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.223105e-01 | 0.374 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.504310e-01 | 0.346 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.504310e-01 | 0.346 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.112078e-01 | 0.386 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.999872e-01 | 0.699 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.793737e-01 | 0.319 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.015618e-01 | 0.300 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.904040e-01 | 0.720 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.654726e-01 | 0.781 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.632581e-01 | 0.580 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.026386e-01 | 0.693 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.738795e-01 | 0.324 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.209462e-01 | 0.283 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.533318e-01 | 0.344 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.732378e-01 | 0.563 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.701719e-01 | 0.769 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.398380e-01 | 0.357 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.575783e-01 | 0.340 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.433527e-01 | 0.844 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.820340e-01 | 0.550 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.820340e-01 | 0.550 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.332461e-01 | 0.632 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.389592e-01 | 0.857 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 1.808522e-01 | 0.743 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.379876e-01 | 0.860 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.947065e-01 | 0.531 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.927531e-01 | 0.406 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.223105e-01 | 0.374 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.223105e-01 | 0.374 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.223105e-01 | 0.374 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.223105e-01 | 0.374 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.623452e-01 | 0.581 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.083662e-01 | 0.511 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.353887e-01 | 0.474 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.026367e-01 | 0.299 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.268514e-01 | 0.278 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.268514e-01 | 0.278 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.733476e-01 | 0.428 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.398380e-01 | 0.357 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.055720e-01 | 0.296 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.473459e-01 | 0.459 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.371471e-01 | 0.359 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.999193e-01 | 0.523 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.223105e-01 | 0.374 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.915484e-01 | 0.535 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.616853e-01 | 0.442 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.328301e-01 | 0.877 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.328301e-01 | 0.877 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.952356e-01 | 0.530 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.248200e-01 | 0.280 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.218350e-01 | 0.282 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.181507e-01 | 0.497 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.725818e-01 | 0.565 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.738795e-01 | 0.324 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.800672e-01 | 0.319 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.956622e-01 | 0.403 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.362673e-01 | 0.473 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.083662e-01 | 0.511 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.697766e-01 | 0.432 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.495502e-01 | 0.456 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.859462e-01 | 0.313 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.586294e-01 | 0.587 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.947065e-01 | 0.531 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 3.290301e-01 | 0.483 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.084287e-01 | 0.681 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.927531e-01 | 0.406 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 3.927531e-01 | 0.406 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 2.816086e-01 | 0.550 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.223105e-01 | 0.374 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.504310e-01 | 0.346 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.504310e-01 | 0.346 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.771842e-01 | 0.321 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.026367e-01 | 0.299 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.241220e-01 | 0.373 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.268514e-01 | 0.278 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.956622e-01 | 0.403 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.936142e-01 | 0.307 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.593064e-01 | 0.445 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.195102e-01 | 0.377 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.464602e-01 | 0.608 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.417783e-01 | 0.355 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.771842e-01 | 0.321 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.464602e-01 | 0.608 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.504310e-01 | 0.346 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.504310e-01 | 0.346 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.720314e-01 | 0.429 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.218761e-01 | 0.492 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.830212e-01 | 0.316 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.654726e-01 | 0.781 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.507744e-01 | 0.822 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.287696e-01 | 0.368 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.738795e-01 | 0.324 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.417783e-01 | 0.355 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.898805e-01 | 0.310 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.947065e-01 | 0.531 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.290301e-01 | 0.483 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.290301e-01 | 0.483 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.084287e-01 | 0.681 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.616853e-01 | 0.442 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.927531e-01 | 0.406 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.927531e-01 | 0.406 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.816086e-01 | 0.550 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.504310e-01 | 0.346 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.504310e-01 | 0.346 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.083662e-01 | 0.511 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 4.771842e-01 | 0.321 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.026367e-01 | 0.299 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 5.026367e-01 | 0.299 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.026367e-01 | 0.299 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.026367e-01 | 0.299 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.112549e-01 | 0.291 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.387506e-01 | 0.858 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.307657e-01 | 0.480 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.946894e-01 | 0.306 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.891544e-01 | 0.723 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.449116e-01 | 0.611 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.695800e-01 | 0.771 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.156543e-01 | 0.381 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.842049e-01 | 0.546 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.547134e-01 | 0.594 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.820340e-01 | 0.550 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.464436e-01 | 0.460 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.680306e-01 | 0.572 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.068521e-01 | 0.684 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.551098e-01 | 0.809 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.509697e-01 | 0.455 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.083662e-01 | 0.511 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.535724e-01 | 0.814 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.992002e-01 | 0.701 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.504310e-01 | 0.346 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.771842e-01 | 0.321 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.026367e-01 | 0.299 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.026367e-01 | 0.299 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.371471e-01 | 0.359 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.178026e-01 | 0.379 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.243981e-01 | 0.489 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.288699e-01 | 0.368 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.504310e-01 | 0.346 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.379876e-01 | 0.860 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.223105e-01 | 0.374 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.504310e-01 | 0.346 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.623568e-01 | 0.441 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.181507e-01 | 0.497 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.055720e-01 | 0.296 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.738795e-01 | 0.324 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.365578e-01 | 0.865 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.898805e-01 | 0.310 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.163564e-01 | 0.287 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.241220e-01 | 0.373 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.290919e-01 | 0.276 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.306258e-01 | 0.275 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.309217e-01 | 0.275 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.359968e-01 | 0.271 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.359968e-01 | 0.271 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.359968e-01 | 0.271 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.359968e-01 | 0.271 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.359968e-01 | 0.271 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.359968e-01 | 0.271 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.359968e-01 | 0.271 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.409409e-01 | 0.267 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.442426e-01 | 0.264 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.451000e-01 | 0.264 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.451000e-01 | 0.264 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.488581e-01 | 0.261 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.498887e-01 | 0.260 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.498887e-01 | 0.260 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.498887e-01 | 0.260 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.498887e-01 | 0.260 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.498887e-01 | 0.260 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.498887e-01 | 0.260 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.498887e-01 | 0.260 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.498887e-01 | 0.260 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.498887e-01 | 0.260 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.498887e-01 | 0.260 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.498887e-01 | 0.260 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.498887e-01 | 0.260 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.498887e-01 | 0.260 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.498887e-01 | 0.260 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.498887e-01 | 0.260 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.498887e-01 | 0.260 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.498887e-01 | 0.260 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.498887e-01 | 0.260 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.498887e-01 | 0.260 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.498887e-01 | 0.260 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.498887e-01 | 0.260 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.498887e-01 | 0.260 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.498887e-01 | 0.260 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.498887e-01 | 0.260 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 5.507188e-01 | 0.259 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.523364e-01 | 0.258 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.523364e-01 | 0.258 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.536558e-01 | 0.257 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.649230e-01 | 0.248 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.651086e-01 | 0.248 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.664585e-01 | 0.247 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.718056e-01 | 0.243 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.718056e-01 | 0.243 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.718056e-01 | 0.243 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 5.718056e-01 | 0.243 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.718056e-01 | 0.243 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.718056e-01 | 0.243 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 5.718056e-01 | 0.243 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.718056e-01 | 0.243 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.718056e-01 | 0.243 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.751258e-01 | 0.240 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.791636e-01 | 0.237 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.791636e-01 | 0.237 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.791636e-01 | 0.237 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.791636e-01 | 0.237 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.791636e-01 | 0.237 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.791636e-01 | 0.237 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.837013e-01 | 0.234 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.840291e-01 | 0.234 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.840291e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.842621e-01 | 0.233 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.842621e-01 | 0.233 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 5.865584e-01 | 0.232 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.865584e-01 | 0.232 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.921827e-01 | 0.228 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.926566e-01 | 0.227 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.926566e-01 | 0.227 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.926566e-01 | 0.227 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.926566e-01 | 0.227 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.926566e-01 | 0.227 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.926566e-01 | 0.227 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.926566e-01 | 0.227 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.926566e-01 | 0.227 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.926566e-01 | 0.227 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.926566e-01 | 0.227 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.926566e-01 | 0.227 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.928824e-01 | 0.227 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.928824e-01 | 0.227 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.928824e-01 | 0.227 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.928824e-01 | 0.227 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.974996e-01 | 0.224 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.051683e-01 | 0.218 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.062642e-01 | 0.217 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.062642e-01 | 0.217 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.062642e-01 | 0.217 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.073060e-01 | 0.217 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.088547e-01 | 0.215 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.124790e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.124935e-01 | 0.213 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.124935e-01 | 0.213 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.124935e-01 | 0.213 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.124935e-01 | 0.213 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.124935e-01 | 0.213 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.124935e-01 | 0.213 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.124935e-01 | 0.213 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.124935e-01 | 0.213 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.124935e-01 | 0.213 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.124935e-01 | 0.213 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.124935e-01 | 0.213 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.124935e-01 | 0.213 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.124935e-01 | 0.213 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.124935e-01 | 0.213 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.124935e-01 | 0.213 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.124935e-01 | 0.213 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.124935e-01 | 0.213 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.170415e-01 | 0.210 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.188068e-01 | 0.208 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.188068e-01 | 0.208 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.193095e-01 | 0.208 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 6.214006e-01 | 0.207 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.313655e-01 | 0.200 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.313655e-01 | 0.200 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.313655e-01 | 0.200 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.313655e-01 | 0.200 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.313655e-01 | 0.200 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.313655e-01 | 0.200 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.313655e-01 | 0.200 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.313655e-01 | 0.200 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.313655e-01 | 0.200 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.313655e-01 | 0.200 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.313655e-01 | 0.200 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.320192e-01 | 0.199 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.320192e-01 | 0.199 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.320192e-01 | 0.199 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.320192e-01 | 0.199 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.320192e-01 | 0.199 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.320192e-01 | 0.199 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.320192e-01 | 0.199 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.330861e-01 | 0.199 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.365708e-01 | 0.196 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.391660e-01 | 0.194 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.443175e-01 | 0.191 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.443950e-01 | 0.191 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 6.443950e-01 | 0.191 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.443950e-01 | 0.191 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.487569e-01 | 0.188 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.493041e-01 | 0.188 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.493195e-01 | 0.188 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.493195e-01 | 0.188 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.493195e-01 | 0.188 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.493195e-01 | 0.188 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.493195e-01 | 0.188 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.493195e-01 | 0.188 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.493195e-01 | 0.188 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.493195e-01 | 0.188 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.493195e-01 | 0.188 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.564394e-01 | 0.183 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.564394e-01 | 0.183 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.590753e-01 | 0.181 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.590753e-01 | 0.181 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.600332e-01 | 0.180 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.626655e-01 | 0.179 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.639776e-01 | 0.178 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.664000e-01 | 0.176 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.664000e-01 | 0.176 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.664000e-01 | 0.176 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.664000e-01 | 0.176 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.664000e-01 | 0.176 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.664000e-01 | 0.176 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.664000e-01 | 0.176 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.664000e-01 | 0.176 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.664000e-01 | 0.176 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.681553e-01 | 0.175 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.681553e-01 | 0.175 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.681553e-01 | 0.175 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.681553e-01 | 0.175 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.686485e-01 | 0.175 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.686485e-01 | 0.175 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 6.686485e-01 | 0.175 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.727786e-01 | 0.172 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.773924e-01 | 0.169 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.780236e-01 | 0.169 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.780236e-01 | 0.169 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.781629e-01 | 0.169 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.783312e-01 | 0.169 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.787630e-01 | 0.168 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.787630e-01 | 0.168 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.795460e-01 | 0.168 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.795460e-01 | 0.168 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.795460e-01 | 0.168 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.795460e-01 | 0.168 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.795460e-01 | 0.168 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.795460e-01 | 0.168 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.795460e-01 | 0.168 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.826497e-01 | 0.166 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.826497e-01 | 0.166 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.826497e-01 | 0.166 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.826497e-01 | 0.166 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.826497e-01 | 0.166 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.826497e-01 | 0.166 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.826497e-01 | 0.166 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.826497e-01 | 0.166 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.826497e-01 | 0.166 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.826497e-01 | 0.166 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.872010e-01 | 0.163 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.872010e-01 | 0.163 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.872010e-01 | 0.163 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.906155e-01 | 0.161 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.906155e-01 | 0.161 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.918304e-01 | 0.160 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.981087e-01 | 0.156 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.981087e-01 | 0.156 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.981087e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.981087e-01 | 0.156 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.981087e-01 | 0.156 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.981087e-01 | 0.156 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.981087e-01 | 0.156 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.981087e-01 | 0.156 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.981087e-01 | 0.156 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.981087e-01 | 0.156 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.981087e-01 | 0.156 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.001139e-01 | 0.155 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.013680e-01 | 0.154 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.013680e-01 | 0.154 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.013680e-01 | 0.154 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.013680e-01 | 0.154 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.033715e-01 | 0.153 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.118081e-01 | 0.148 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.118081e-01 | 0.148 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.118081e-01 | 0.148 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.121811e-01 | 0.147 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.121811e-01 | 0.147 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.128156e-01 | 0.147 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.128156e-01 | 0.147 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.128156e-01 | 0.147 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.128156e-01 | 0.147 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.128156e-01 | 0.147 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.128156e-01 | 0.147 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.128156e-01 | 0.147 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.128156e-01 | 0.147 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.128156e-01 | 0.147 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.137917e-01 | 0.146 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.137917e-01 | 0.146 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.149905e-01 | 0.146 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.195848e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.207105e-01 | 0.142 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.219407e-01 | 0.141 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.219407e-01 | 0.141 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.268069e-01 | 0.139 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.268069e-01 | 0.139 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.268069e-01 | 0.139 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.268069e-01 | 0.139 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.268069e-01 | 0.139 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.268069e-01 | 0.139 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.268069e-01 | 0.139 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.268069e-01 | 0.139 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.268069e-01 | 0.139 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.268069e-01 | 0.139 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.268069e-01 | 0.139 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.270231e-01 | 0.138 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.300479e-01 | 0.137 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.317710e-01 | 0.136 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.339679e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.401174e-01 | 0.131 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.401174e-01 | 0.131 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.401174e-01 | 0.131 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.401174e-01 | 0.131 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.401174e-01 | 0.131 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.401174e-01 | 0.131 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.401174e-01 | 0.131 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.401174e-01 | 0.131 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.405512e-01 | 0.130 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.413044e-01 | 0.130 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.413044e-01 | 0.130 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.413044e-01 | 0.130 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.413044e-01 | 0.130 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.413044e-01 | 0.130 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.459772e-01 | 0.127 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.464526e-01 | 0.127 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.477892e-01 | 0.126 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.505464e-01 | 0.125 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.505464e-01 | 0.125 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.505464e-01 | 0.125 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.505464e-01 | 0.125 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.505464e-01 | 0.125 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.505464e-01 | 0.125 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.515845e-01 | 0.124 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.520937e-01 | 0.124 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.521496e-01 | 0.124 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.527801e-01 | 0.123 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.527801e-01 | 0.123 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.527801e-01 | 0.123 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.527801e-01 | 0.123 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.527801e-01 | 0.123 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.527801e-01 | 0.123 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.527801e-01 | 0.123 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.527801e-01 | 0.123 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.527801e-01 | 0.123 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.527801e-01 | 0.123 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.536098e-01 | 0.123 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.536098e-01 | 0.123 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.556862e-01 | 0.122 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.595029e-01 | 0.119 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.648265e-01 | 0.116 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.648265e-01 | 0.116 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.648265e-01 | 0.116 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.674815e-01 | 0.115 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.681796e-01 | 0.115 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.683206e-01 | 0.114 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.735903e-01 | 0.111 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.737723e-01 | 0.111 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.737723e-01 | 0.111 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 7.754033e-01 | 0.110 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.755129e-01 | 0.110 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.755129e-01 | 0.110 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.762867e-01 | 0.110 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.762867e-01 | 0.110 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.762867e-01 | 0.110 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.762867e-01 | 0.110 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.762867e-01 | 0.110 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.762867e-01 | 0.110 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.762867e-01 | 0.110 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 7.762867e-01 | 0.110 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.762867e-01 | 0.110 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.765826e-01 | 0.110 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.799285e-01 | 0.108 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.810823e-01 | 0.107 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.825457e-01 | 0.106 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.847179e-01 | 0.105 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.859031e-01 | 0.105 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.859513e-01 | 0.105 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.871890e-01 | 0.104 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.871890e-01 | 0.104 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.871890e-01 | 0.104 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.871890e-01 | 0.104 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.871890e-01 | 0.104 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.871890e-01 | 0.104 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.871890e-01 | 0.104 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.871890e-01 | 0.104 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.871890e-01 | 0.104 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.871890e-01 | 0.104 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.871890e-01 | 0.104 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.890353e-01 | 0.103 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.918419e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.918419e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.918419e-01 | 0.101 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.918419e-01 | 0.101 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.919005e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.919005e-01 | 0.101 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.925916e-01 | 0.101 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.925916e-01 | 0.101 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.925916e-01 | 0.101 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.939476e-01 | 0.100 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.939476e-01 | 0.100 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.939476e-01 | 0.100 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.975607e-01 | 0.098 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.975607e-01 | 0.098 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.975607e-01 | 0.098 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.975607e-01 | 0.098 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.975607e-01 | 0.098 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.975607e-01 | 0.098 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.002100e-01 | 0.097 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.019733e-01 | 0.096 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.019733e-01 | 0.096 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.073389e-01 | 0.093 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.073389e-01 | 0.093 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.074275e-01 | 0.093 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.074275e-01 | 0.093 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.074275e-01 | 0.093 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.074275e-01 | 0.093 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.074275e-01 | 0.093 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.074275e-01 | 0.093 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.074275e-01 | 0.093 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.075791e-01 | 0.093 | 1 | 1 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.087358e-01 | 0.092 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.145480e-01 | 0.089 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.147052e-01 | 0.089 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.168139e-01 | 0.088 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.168139e-01 | 0.088 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.168139e-01 | 0.088 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.168139e-01 | 0.088 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.168139e-01 | 0.088 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.171164e-01 | 0.088 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.171834e-01 | 0.088 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.184836e-01 | 0.087 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.193654e-01 | 0.087 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.215944e-01 | 0.085 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.215944e-01 | 0.085 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.244952e-01 | 0.084 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.257434e-01 | 0.083 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 8.257434e-01 | 0.083 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.257434e-01 | 0.083 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.257434e-01 | 0.083 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.257434e-01 | 0.083 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.257434e-01 | 0.083 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.257434e-01 | 0.083 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.257434e-01 | 0.083 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.282529e-01 | 0.082 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.282529e-01 | 0.082 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.308070e-01 | 0.080 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.314259e-01 | 0.080 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.342381e-01 | 0.079 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.342381e-01 | 0.079 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.342381e-01 | 0.079 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.343062e-01 | 0.079 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.346868e-01 | 0.078 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.354742e-01 | 0.078 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.391650e-01 | 0.076 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.398209e-01 | 0.076 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.409022e-01 | 0.075 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.417673e-01 | 0.075 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.421103e-01 | 0.075 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.423193e-01 | 0.075 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.423193e-01 | 0.075 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.423193e-01 | 0.075 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.423193e-01 | 0.075 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.423193e-01 | 0.075 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.423193e-01 | 0.075 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.423193e-01 | 0.075 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.423193e-01 | 0.075 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.423193e-01 | 0.075 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.469050e-01 | 0.072 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.469050e-01 | 0.072 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.481054e-01 | 0.072 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.483631e-01 | 0.071 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.495247e-01 | 0.071 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.500069e-01 | 0.071 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.500069e-01 | 0.071 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.500858e-01 | 0.071 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.522035e-01 | 0.069 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.522035e-01 | 0.069 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.527012e-01 | 0.069 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.527012e-01 | 0.069 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.527012e-01 | 0.069 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.527012e-01 | 0.069 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.527012e-01 | 0.069 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.527012e-01 | 0.069 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.527931e-01 | 0.069 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.561146e-01 | 0.067 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.573201e-01 | 0.067 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.573201e-01 | 0.067 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.573201e-01 | 0.067 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.582967e-01 | 0.066 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.582967e-01 | 0.066 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.582967e-01 | 0.066 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.630679e-01 | 0.064 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.636972e-01 | 0.064 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.636972e-01 | 0.064 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.642772e-01 | 0.063 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.642772e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.642772e-01 | 0.063 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.642772e-01 | 0.063 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.642772e-01 | 0.063 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.642772e-01 | 0.063 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.653630e-01 | 0.063 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.654290e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.694293e-01 | 0.061 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.707123e-01 | 0.060 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.708955e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.708955e-01 | 0.060 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.708955e-01 | 0.060 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.708955e-01 | 0.060 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.708955e-01 | 0.060 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.708955e-01 | 0.060 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.708955e-01 | 0.060 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.708955e-01 | 0.060 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.708955e-01 | 0.060 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.771914e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.771914e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.771914e-01 | 0.057 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.771914e-01 | 0.057 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.771914e-01 | 0.057 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.771914e-01 | 0.057 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.771914e-01 | 0.057 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.771914e-01 | 0.057 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.782900e-01 | 0.056 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.787856e-01 | 0.056 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.795265e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.808217e-01 | 0.055 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.816660e-01 | 0.055 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.831807e-01 | 0.054 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.831807e-01 | 0.054 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.831807e-01 | 0.054 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.849617e-01 | 0.053 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.879717e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.879717e-01 | 0.052 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.888782e-01 | 0.051 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.888782e-01 | 0.051 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.888782e-01 | 0.051 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.888782e-01 | 0.051 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.888782e-01 | 0.051 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.888782e-01 | 0.051 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.888782e-01 | 0.051 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.888782e-01 | 0.051 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.888782e-01 | 0.051 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 8.888782e-01 | 0.051 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.904504e-01 | 0.050 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.913412e-01 | 0.050 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.923187e-01 | 0.049 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.942982e-01 | 0.049 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.942982e-01 | 0.049 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.946379e-01 | 0.048 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.975654e-01 | 0.047 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.984386e-01 | 0.047 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.994541e-01 | 0.046 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.994541e-01 | 0.046 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.994541e-01 | 0.046 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.002840e-01 | 0.046 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.005464e-01 | 0.045 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.040495e-01 | 0.044 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.040973e-01 | 0.044 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.043588e-01 | 0.044 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.043588e-01 | 0.044 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.043588e-01 | 0.044 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.043588e-01 | 0.044 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.044369e-01 | 0.044 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.081848e-01 | 0.042 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.081848e-01 | 0.042 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.090246e-01 | 0.041 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.090246e-01 | 0.041 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.090246e-01 | 0.041 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.090246e-01 | 0.041 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.090246e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.090246e-01 | 0.041 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.134630e-01 | 0.039 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.134630e-01 | 0.039 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.134630e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.134630e-01 | 0.039 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.134630e-01 | 0.039 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.145109e-01 | 0.039 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.145109e-01 | 0.039 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.176851e-01 | 0.037 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.176851e-01 | 0.037 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.176851e-01 | 0.037 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.186191e-01 | 0.037 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.207874e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.217015e-01 | 0.035 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.217015e-01 | 0.035 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.217015e-01 | 0.035 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.218421e-01 | 0.035 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.236288e-01 | 0.035 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.249446e-01 | 0.034 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.250180e-01 | 0.034 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.255221e-01 | 0.034 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.283980e-01 | 0.032 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.291565e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.291565e-01 | 0.032 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.291565e-01 | 0.032 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.291565e-01 | 0.032 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.308044e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.309140e-01 | 0.031 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.320955e-01 | 0.031 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.326138e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.335695e-01 | 0.030 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.335695e-01 | 0.030 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.339733e-01 | 0.030 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.359026e-01 | 0.029 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.359026e-01 | 0.029 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.359026e-01 | 0.029 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.359026e-01 | 0.029 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.362298e-01 | 0.029 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.390310e-01 | 0.027 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.390310e-01 | 0.027 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.390310e-01 | 0.027 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.390310e-01 | 0.027 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.412502e-01 | 0.026 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.420070e-01 | 0.026 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.423162e-01 | 0.026 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.423162e-01 | 0.026 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.475306e-01 | 0.023 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.475306e-01 | 0.023 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.480823e-01 | 0.023 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.499520e-01 | 0.022 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.500922e-01 | 0.022 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.500922e-01 | 0.022 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.522089e-01 | 0.021 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.525288e-01 | 0.021 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.525288e-01 | 0.021 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.532198e-01 | 0.021 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.536902e-01 | 0.021 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.553690e-01 | 0.020 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.553690e-01 | 0.020 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.570513e-01 | 0.019 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.577211e-01 | 0.019 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.578163e-01 | 0.019 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.591486e-01 | 0.018 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.591486e-01 | 0.018 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.591486e-01 | 0.018 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.599197e-01 | 0.018 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.605046e-01 | 0.018 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.611435e-01 | 0.017 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.611435e-01 | 0.017 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.627905e-01 | 0.016 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.630412e-01 | 0.016 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.630412e-01 | 0.016 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.630412e-01 | 0.016 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.640090e-01 | 0.016 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.640090e-01 | 0.016 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.648463e-01 | 0.016 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.649281e-01 | 0.016 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.665633e-01 | 0.015 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.665633e-01 | 0.015 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.681965e-01 | 0.014 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.689978e-01 | 0.014 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.697501e-01 | 0.013 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.697501e-01 | 0.013 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.720445e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.723012e-01 | 0.012 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.726336e-01 | 0.012 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.748370e-01 | 0.011 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.764522e-01 | 0.010 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.764522e-01 | 0.010 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.765510e-01 | 0.010 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.782149e-01 | 0.010 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.794447e-01 | 0.009 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.797386e-01 | 0.009 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.803680e-01 | 0.009 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.807289e-01 | 0.008 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.807289e-01 | 0.008 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.816708e-01 | 0.008 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.842296e-01 | 0.007 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.842296e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.842296e-01 | 0.007 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.850006e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.852803e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.854321e-01 | 0.006 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.864316e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.864316e-01 | 0.006 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.870951e-01 | 0.006 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.877262e-01 | 0.005 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.883264e-01 | 0.005 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.887819e-01 | 0.005 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.899004e-01 | 0.004 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.899569e-01 | 0.004 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.909301e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.911238e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.911624e-01 | 0.004 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.917827e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.918415e-01 | 0.004 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.924701e-01 | 0.003 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.937055e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.939188e-01 | 0.003 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.939188e-01 | 0.003 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.952685e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.957853e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.968398e-01 | 0.001 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.971364e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.979681e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.985187e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.988215e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.988412e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.990035e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.991431e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.993664e-01 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.993700e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994522e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.995231e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.995545e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.995699e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997473e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.998454e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998760e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999237e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999344e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999344e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999490e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999500e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999523e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999624e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999656e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999660e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999709e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999876e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999882e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999905e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999969e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999978e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.469174e-10 | 9.607 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.052688e-10 | 9.392 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.427737e-10 | 9.265 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.547049e-09 | 8.810 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.966703e-08 | 7.099 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.266598e-07 | 6.897 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.874375e-07 | 6.727 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.026485e-07 | 6.519 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.902684e-06 | 5.721 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.750388e-06 | 5.561 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.772251e-06 | 5.423 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.359831e-05 | 4.867 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.013363e-05 | 4.696 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.439871e-05 | 4.613 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.467404e-05 | 4.608 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.206955e-05 | 4.656 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.511157e-05 | 4.259 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.632415e-05 | 4.249 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.645569e-05 | 4.177 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.257567e-05 | 4.139 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.597386e-05 | 4.119 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.142031e-05 | 4.089 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.625258e-05 | 4.017 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.672758e-04 | 3.777 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.768208e-04 | 3.752 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.050424e-04 | 3.688 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.804757e-04 | 3.552 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.458231e-04 | 3.461 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.024487e-04 | 3.519 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.207971e-04 | 3.494 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.561060e-04 | 3.448 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.119018e-04 | 3.506 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.581772e-04 | 3.446 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.581772e-04 | 3.446 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.049044e-04 | 3.393 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.118598e-04 | 3.385 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.517681e-04 | 3.258 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.127887e-04 | 3.290 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.881227e-04 | 3.311 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.275369e-04 | 3.278 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.098516e-04 | 3.293 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.376746e-04 | 3.269 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.383816e-04 | 3.269 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.433192e-04 | 3.265 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.507963e-04 | 3.187 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.998699e-04 | 3.155 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.177907e-04 | 3.087 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.342288e-04 | 3.079 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.319201e-04 | 3.080 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.098830e-04 | 3.041 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.517290e-04 | 3.021 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.741388e-04 | 3.011 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.258818e-03 | 2.900 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.200693e-03 | 2.921 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.224760e-03 | 2.912 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.291590e-03 | 2.889 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.153789e-03 | 2.938 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.258818e-03 | 2.900 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.564541e-03 | 2.806 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.643122e-03 | 2.784 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.643122e-03 | 2.784 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.740160e-03 | 2.759 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.689776e-03 | 2.772 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.077116e-03 | 2.683 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.089216e-03 | 2.680 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.337133e-03 | 2.631 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.450049e-03 | 2.611 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.649026e-03 | 2.577 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.673843e-03 | 2.573 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 3.153965e-03 | 2.501 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.019115e-03 | 2.396 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.019115e-03 | 2.396 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.986237e-03 | 2.399 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.023154e-03 | 2.395 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.272914e-03 | 2.369 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.232191e-03 | 2.373 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.272914e-03 | 2.369 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.119276e-03 | 2.385 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.272914e-03 | 2.369 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.167725e-03 | 2.287 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.167725e-03 | 2.287 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.052906e-03 | 2.296 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.833998e-03 | 2.316 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.172424e-03 | 2.286 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.119616e-03 | 2.291 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.319829e-03 | 2.274 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.984219e-03 | 2.223 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.731223e-03 | 2.242 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.731223e-03 | 2.242 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.163905e-03 | 2.210 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.049343e-03 | 2.218 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.163905e-03 | 2.210 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.897013e-03 | 2.229 | 1 | 1 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.897591e-03 | 2.229 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.193126e-03 | 2.208 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.963892e-03 | 2.224 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.428185e-03 | 2.192 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.428185e-03 | 2.192 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.691667e-03 | 2.174 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.410561e-03 | 2.193 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.678447e-03 | 2.175 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.933356e-03 | 2.159 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.110335e-03 | 2.148 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.264292e-03 | 2.083 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.017550e-03 | 2.096 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.953641e-03 | 2.099 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.814801e-03 | 2.107 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.403268e-03 | 2.076 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.403268e-03 | 2.076 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.420810e-03 | 2.075 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.546417e-03 | 2.068 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.573849e-03 | 2.067 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 9.252617e-03 | 2.034 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.173960e-03 | 2.037 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.023729e-03 | 2.045 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 9.605436e-03 | 2.017 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.470329e-03 | 2.024 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.462456e-03 | 2.024 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.935968e-03 | 2.003 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.653490e-03 | 2.015 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.472248e-03 | 2.024 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.751324e-03 | 2.011 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.007279e-02 | 1.997 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.027036e-02 | 1.988 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.027036e-02 | 1.988 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.081387e-02 | 1.966 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.081387e-02 | 1.966 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.090762e-02 | 1.962 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.130572e-02 | 1.947 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.195510e-02 | 1.922 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.159077e-02 | 1.936 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.231375e-02 | 1.910 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.293206e-02 | 1.888 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.295232e-02 | 1.888 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.295232e-02 | 1.888 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.368331e-02 | 1.864 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.385122e-02 | 1.859 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.411294e-02 | 1.850 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.418153e-02 | 1.848 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.385122e-02 | 1.859 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.467335e-02 | 1.833 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.484092e-02 | 1.829 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.511689e-02 | 1.821 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.634687e-02 | 1.787 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.597567e-02 | 1.797 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.670182e-02 | 1.777 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.670182e-02 | 1.777 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.670182e-02 | 1.777 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.670182e-02 | 1.777 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.670182e-02 | 1.777 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.695532e-02 | 1.771 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.730493e-02 | 1.762 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.774609e-02 | 1.751 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.774609e-02 | 1.751 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.834558e-02 | 1.736 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.834558e-02 | 1.736 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.861746e-02 | 1.730 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.876203e-02 | 1.727 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.898563e-02 | 1.722 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.904303e-02 | 1.720 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.009092e-02 | 1.697 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.071099e-02 | 1.684 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.945889e-02 | 1.711 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.907750e-02 | 1.719 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.093380e-02 | 1.679 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.093380e-02 | 1.679 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.184955e-02 | 1.661 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.184955e-02 | 1.661 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.231348e-02 | 1.651 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.199532e-02 | 1.658 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.121376e-02 | 1.673 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.309187e-02 | 1.637 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.203512e-02 | 1.657 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.270663e-02 | 1.644 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.270663e-02 | 1.644 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.184955e-02 | 1.661 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.332123e-02 | 1.632 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.121376e-02 | 1.673 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.280039e-02 | 1.642 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.262079e-02 | 1.645 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.389059e-02 | 1.622 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.417596e-02 | 1.617 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.423888e-02 | 1.615 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.423888e-02 | 1.615 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.423888e-02 | 1.615 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.765062e-02 | 1.558 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.765062e-02 | 1.558 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.765062e-02 | 1.558 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.765062e-02 | 1.558 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.748192e-02 | 1.561 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.748192e-02 | 1.561 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.748192e-02 | 1.561 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.728835e-02 | 1.564 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.481856e-02 | 1.605 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.728835e-02 | 1.564 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.709985e-02 | 1.567 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.613526e-02 | 1.583 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.655288e-02 | 1.576 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.541306e-02 | 1.595 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.562847e-02 | 1.591 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.501273e-02 | 1.602 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.748192e-02 | 1.561 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.132357e-02 | 1.504 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.912806e-02 | 1.536 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.912806e-02 | 1.536 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.171818e-02 | 1.499 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.172274e-02 | 1.499 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.132357e-02 | 1.504 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.132357e-02 | 1.504 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.795816e-02 | 1.553 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.837889e-02 | 1.547 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.074265e-02 | 1.512 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.863516e-02 | 1.543 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.851775e-02 | 1.545 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.870294e-02 | 1.542 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.904813e-02 | 1.537 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.826532e-02 | 1.549 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.815163e-02 | 1.550 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.851775e-02 | 1.545 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.826532e-02 | 1.549 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.171818e-02 | 1.499 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.179178e-02 | 1.498 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 4.192227e-02 | 1.378 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.192227e-02 | 1.378 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.192227e-02 | 1.378 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 4.192227e-02 | 1.378 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 4.192227e-02 | 1.378 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.183713e-02 | 1.378 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.183713e-02 | 1.378 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.426613e-02 | 1.465 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.662501e-02 | 1.331 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.662501e-02 | 1.331 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.662501e-02 | 1.331 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.647594e-02 | 1.438 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.647594e-02 | 1.438 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.644160e-02 | 1.438 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.644160e-02 | 1.438 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.523184e-02 | 1.453 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.747820e-02 | 1.426 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.442131e-02 | 1.352 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.063018e-02 | 1.391 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.304277e-02 | 1.366 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.903993e-02 | 1.408 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.756384e-02 | 1.425 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.756384e-02 | 1.425 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.390732e-02 | 1.470 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.242004e-02 | 1.372 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.242004e-02 | 1.372 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.293591e-02 | 1.367 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.485876e-02 | 1.458 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.323028e-02 | 1.364 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.323028e-02 | 1.364 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.903388e-02 | 1.409 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.334040e-02 | 1.363 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.459638e-02 | 1.351 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.707605e-02 | 1.431 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.304277e-02 | 1.366 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.893119e-02 | 1.410 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.707605e-02 | 1.431 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.647594e-02 | 1.438 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.617943e-02 | 1.336 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.569397e-02 | 1.340 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.053315e-02 | 1.392 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.747820e-02 | 1.426 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.977390e-02 | 1.400 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.304277e-02 | 1.366 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.442131e-02 | 1.352 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.673361e-02 | 1.330 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.183713e-02 | 1.378 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.304277e-02 | 1.366 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.304277e-02 | 1.366 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.923834e-02 | 1.406 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.163747e-02 | 1.381 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.044035e-02 | 1.393 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.377941e-02 | 1.471 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.341929e-02 | 1.476 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.053315e-02 | 1.392 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.867259e-02 | 1.413 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.593952e-02 | 1.338 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.593952e-02 | 1.338 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.447496e-02 | 1.462 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.242004e-02 | 1.372 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.423115e-02 | 1.466 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.542267e-02 | 1.451 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.426613e-02 | 1.465 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.662501e-02 | 1.331 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.646890e-02 | 1.438 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.341929e-02 | 1.476 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.707605e-02 | 1.431 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.569397e-02 | 1.340 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.752091e-02 | 1.426 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.426613e-02 | 1.465 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.903993e-02 | 1.408 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.183713e-02 | 1.378 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.183713e-02 | 1.378 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.710644e-02 | 1.327 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.710644e-02 | 1.327 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.711976e-02 | 1.327 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.716348e-02 | 1.326 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.716348e-02 | 1.326 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.716348e-02 | 1.326 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.716348e-02 | 1.326 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.716348e-02 | 1.326 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.716348e-02 | 1.326 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.716348e-02 | 1.326 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.716348e-02 | 1.326 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.716348e-02 | 1.326 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.716348e-02 | 1.326 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.804677e-02 | 1.318 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.809112e-02 | 1.318 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.887116e-02 | 1.311 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.131138e-02 | 1.212 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.244110e-02 | 1.280 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.244110e-02 | 1.280 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.732267e-02 | 1.242 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.124751e-02 | 1.290 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.907298e-02 | 1.229 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.348063e-02 | 1.272 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.044405e-02 | 1.219 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.069186e-02 | 1.217 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.060857e-02 | 1.217 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.494793e-02 | 1.260 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.494793e-02 | 1.260 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.494793e-02 | 1.260 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.690665e-02 | 1.245 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.124751e-02 | 1.290 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.964436e-02 | 1.224 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.960183e-02 | 1.225 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.344544e-02 | 1.272 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.951547e-02 | 1.225 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.230044e-02 | 1.281 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.823744e-02 | 1.235 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.252256e-02 | 1.280 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.321930e-02 | 1.274 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.079449e-02 | 1.294 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.871179e-02 | 1.231 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.010236e-02 | 1.300 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.951547e-02 | 1.225 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.180855e-02 | 1.286 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.076046e-02 | 1.216 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.276034e-02 | 1.278 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.964890e-02 | 1.304 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.732267e-02 | 1.242 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.732267e-02 | 1.242 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.931511e-02 | 1.227 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.494793e-02 | 1.260 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.871179e-02 | 1.231 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.823744e-02 | 1.235 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.964520e-02 | 1.304 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.690665e-02 | 1.245 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.690665e-02 | 1.245 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.131138e-02 | 1.212 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.358466e-02 | 1.271 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.427752e-02 | 1.265 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.494793e-02 | 1.260 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.964436e-02 | 1.224 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.174314e-02 | 1.209 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.187833e-02 | 1.208 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.254179e-02 | 1.204 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.276914e-02 | 1.202 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.322916e-02 | 1.199 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.363450e-02 | 1.196 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.458645e-02 | 1.190 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.529901e-02 | 1.185 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.538493e-02 | 1.185 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.589335e-02 | 1.181 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.591472e-02 | 1.181 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.648460e-02 | 1.177 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.724673e-02 | 1.172 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.930177e-02 | 1.159 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.973351e-02 | 1.157 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.029417e-02 | 1.153 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.029417e-02 | 1.153 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.085194e-02 | 1.150 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.205568e-02 | 1.142 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.228393e-02 | 1.141 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.228393e-02 | 1.141 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.228393e-02 | 1.141 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.313579e-02 | 1.136 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 8.504635e-02 | 1.070 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 8.504635e-02 | 1.070 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.408217e-02 | 1.130 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.408217e-02 | 1.130 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.408217e-02 | 1.130 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 7.408217e-02 | 1.130 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 7.408217e-02 | 1.130 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 7.408217e-02 | 1.130 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.008743e-02 | 1.096 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.008743e-02 | 1.096 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 8.008743e-02 | 1.096 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 8.008743e-02 | 1.096 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.832207e-02 | 1.106 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.832207e-02 | 1.106 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.832207e-02 | 1.106 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.832207e-02 | 1.106 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.979074e-02 | 1.047 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.979074e-02 | 1.047 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.428056e-02 | 1.129 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.014500e-02 | 1.045 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.066989e-02 | 1.093 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.066989e-02 | 1.093 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.066989e-02 | 1.093 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.281820e-02 | 1.082 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.281820e-02 | 1.082 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.458370e-02 | 1.073 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.511753e-02 | 1.022 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.058925e-02 | 1.043 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.281820e-02 | 1.082 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.818524e-02 | 1.107 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.294346e-02 | 1.081 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.408430e-02 | 1.026 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.408430e-02 | 1.026 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.832207e-02 | 1.106 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.245713e-02 | 1.034 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.711458e-02 | 1.060 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.381427e-02 | 1.132 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.759677e-02 | 1.011 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.066989e-02 | 1.093 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.286400e-02 | 1.082 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.126834e-02 | 1.090 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.394842e-02 | 1.131 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.504635e-02 | 1.070 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.979074e-02 | 1.047 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.511753e-02 | 1.022 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.381427e-02 | 1.132 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.381427e-02 | 1.132 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.245713e-02 | 1.034 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.014500e-02 | 1.045 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 7.408217e-02 | 1.130 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.759677e-02 | 1.011 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 9.759677e-02 | 1.011 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.185538e-02 | 1.087 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.014500e-02 | 1.045 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.348014e-02 | 1.134 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.245713e-02 | 1.034 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.793283e-02 | 1.009 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.286686e-02 | 1.032 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.348014e-02 | 1.134 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.286400e-02 | 1.082 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.408430e-02 | 1.026 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.610909e-02 | 1.119 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.871374e-02 | 1.006 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.918179e-02 | 1.004 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.960595e-02 | 1.002 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.008724e-01 | 0.996 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.012744e-01 | 0.995 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.026170e-01 | 0.989 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.026170e-01 | 0.989 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.026170e-01 | 0.989 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.026170e-01 | 0.989 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.026170e-01 | 0.989 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.030856e-01 | 0.987 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.031226e-01 | 0.987 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.036275e-01 | 0.985 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.036275e-01 | 0.985 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.039654e-01 | 0.983 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.039654e-01 | 0.983 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.040973e-01 | 0.983 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.040973e-01 | 0.983 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.040973e-01 | 0.983 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.041801e-01 | 0.982 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.041801e-01 | 0.982 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.045081e-01 | 0.981 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.049894e-01 | 0.979 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.049894e-01 | 0.979 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.049894e-01 | 0.979 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.049894e-01 | 0.979 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 1.049894e-01 | 0.979 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.074895e-01 | 0.969 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.074895e-01 | 0.969 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.137527e-01 | 0.944 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.139254e-01 | 0.943 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.150968e-01 | 0.939 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.156135e-01 | 0.937 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.159272e-01 | 0.936 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.163900e-01 | 0.934 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.169442e-01 | 0.932 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.171045e-01 | 0.931 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.171045e-01 | 0.931 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.171386e-01 | 0.931 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.171386e-01 | 0.931 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.183412e-01 | 0.927 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.190247e-01 | 0.924 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.190247e-01 | 0.924 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.190247e-01 | 0.924 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.190247e-01 | 0.924 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.190247e-01 | 0.924 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.190247e-01 | 0.924 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.190247e-01 | 0.924 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.190247e-01 | 0.924 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.224496e-01 | 0.912 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.236756e-01 | 0.908 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.242694e-01 | 0.906 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.242694e-01 | 0.906 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.260993e-01 | 0.899 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.268400e-01 | 0.897 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.268400e-01 | 0.897 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.268400e-01 | 0.897 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.272665e-01 | 0.895 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 1.486814e-01 | 0.828 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.486814e-01 | 0.828 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.486814e-01 | 0.828 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.486814e-01 | 0.828 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.486814e-01 | 0.828 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.486814e-01 | 0.828 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.486814e-01 | 0.828 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.486814e-01 | 0.828 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.365279e-01 | 0.865 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.400263e-01 | 0.854 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.400263e-01 | 0.854 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.306745e-01 | 0.884 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.306745e-01 | 0.884 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.306745e-01 | 0.884 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.306745e-01 | 0.884 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.783459e-01 | 0.749 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.783459e-01 | 0.749 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.783459e-01 | 0.749 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.598783e-01 | 0.796 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.598783e-01 | 0.796 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.424527e-01 | 0.846 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.676932e-01 | 0.775 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.477458e-01 | 0.830 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.477458e-01 | 0.830 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.477458e-01 | 0.830 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.700888e-01 | 0.769 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.495737e-01 | 0.825 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.320675e-01 | 0.879 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.676970e-01 | 0.775 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.676970e-01 | 0.775 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.676970e-01 | 0.775 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.293742e-01 | 0.888 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.869677e-01 | 0.728 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.869677e-01 | 0.728 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.869677e-01 | 0.728 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.431152e-01 | 0.844 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.776855e-01 | 0.750 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.455843e-01 | 0.837 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.298421e-01 | 0.887 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.846892e-01 | 0.734 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.344147e-01 | 0.872 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.557312e-01 | 0.808 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.508532e-01 | 0.821 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.700888e-01 | 0.769 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.306668e-01 | 0.884 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.477458e-01 | 0.830 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.456976e-01 | 0.837 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.276327e-01 | 0.894 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.727695e-01 | 0.763 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.442382e-01 | 0.841 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.767859e-01 | 0.753 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.598783e-01 | 0.796 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.365279e-01 | 0.865 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.424527e-01 | 0.846 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.536508e-01 | 0.813 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.493906e-01 | 0.826 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.826231e-01 | 0.738 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.487325e-01 | 0.828 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.506095e-01 | 0.822 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.668683e-01 | 0.778 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.336728e-01 | 0.874 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.479788e-01 | 0.830 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.580844e-01 | 0.801 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.826231e-01 | 0.738 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.423063e-01 | 0.847 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.647972e-01 | 0.783 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.477458e-01 | 0.830 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.783459e-01 | 0.749 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.696786e-01 | 0.770 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.375829e-01 | 0.861 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.786013e-01 | 0.748 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.784415e-01 | 0.749 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.892604e-01 | 0.723 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.662261e-01 | 0.779 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.306745e-01 | 0.884 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.424527e-01 | 0.846 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.477458e-01 | 0.830 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.700888e-01 | 0.769 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.431152e-01 | 0.844 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.493906e-01 | 0.826 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.911538e-01 | 0.719 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.912012e-01 | 0.719 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.627042e-01 | 0.789 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.702338e-01 | 0.769 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.702338e-01 | 0.769 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.702338e-01 | 0.769 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.676932e-01 | 0.775 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.401236e-01 | 0.853 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.784415e-01 | 0.749 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.431152e-01 | 0.844 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.460977e-01 | 0.835 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.700888e-01 | 0.769 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.598783e-01 | 0.796 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.495737e-01 | 0.825 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.536508e-01 | 0.813 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.536508e-01 | 0.813 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.580844e-01 | 0.801 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.918545e-01 | 0.717 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.929302e-01 | 0.715 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 1.929302e-01 | 0.715 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.929302e-01 | 0.715 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 1.929302e-01 | 0.715 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.929302e-01 | 0.715 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.929302e-01 | 0.715 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.929302e-01 | 0.715 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.929302e-01 | 0.715 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.937327e-01 | 0.713 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.937327e-01 | 0.713 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.945332e-01 | 0.711 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.945332e-01 | 0.711 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.945332e-01 | 0.711 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.945332e-01 | 0.711 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.945332e-01 | 0.711 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.945332e-01 | 0.711 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.945332e-01 | 0.711 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.949388e-01 | 0.710 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.979781e-01 | 0.703 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.979781e-01 | 0.703 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.987528e-01 | 0.702 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.987528e-01 | 0.702 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.051069e-01 | 0.688 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.071271e-01 | 0.684 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.090250e-01 | 0.680 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.090250e-01 | 0.680 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.098464e-01 | 0.678 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.752638e-01 | 0.560 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 2.752638e-01 | 0.560 | 0 | 0 |
| Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | R-HSA-5619110 | 2.752638e-01 | 0.560 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.752638e-01 | 0.560 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.752638e-01 | 0.560 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.516535e-01 | 0.599 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.516535e-01 | 0.599 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.516535e-01 | 0.599 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.516535e-01 | 0.599 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.830309e-01 | 0.417 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.830309e-01 | 0.417 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 3.830309e-01 | 0.417 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 3.830309e-01 | 0.417 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.830309e-01 | 0.417 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.830309e-01 | 0.417 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.830309e-01 | 0.417 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.830309e-01 | 0.417 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.830309e-01 | 0.417 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.830309e-01 | 0.417 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.830309e-01 | 0.417 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.830309e-01 | 0.417 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.830309e-01 | 0.417 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.830309e-01 | 0.417 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.191038e-01 | 0.659 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.191038e-01 | 0.659 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.191038e-01 | 0.659 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.107614e-01 | 0.508 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.107614e-01 | 0.508 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.614991e-01 | 0.583 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.614991e-01 | 0.583 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.614991e-01 | 0.583 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.614991e-01 | 0.583 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.614991e-01 | 0.583 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.242469e-01 | 0.649 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.227417e-01 | 0.652 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.586152e-01 | 0.587 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.586152e-01 | 0.587 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.586152e-01 | 0.587 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.586152e-01 | 0.587 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.586152e-01 | 0.587 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.048008e-01 | 0.516 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.048008e-01 | 0.516 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.048008e-01 | 0.516 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.048008e-01 | 0.516 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.688420e-01 | 0.433 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.688420e-01 | 0.433 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.688420e-01 | 0.433 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.688420e-01 | 0.433 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.688420e-01 | 0.433 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.688420e-01 | 0.433 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.688420e-01 | 0.433 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.520780e-01 | 0.598 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.520780e-01 | 0.598 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.939141e-01 | 0.532 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.130982e-01 | 0.671 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.483612e-01 | 0.458 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.483612e-01 | 0.458 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.483612e-01 | 0.458 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.483612e-01 | 0.458 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.361958e-01 | 0.627 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.709236e-01 | 0.567 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.709236e-01 | 0.567 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.709236e-01 | 0.567 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.297707e-01 | 0.482 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.131580e-01 | 0.504 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.400540e-01 | 0.620 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.658377e-01 | 0.437 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.658377e-01 | 0.437 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.658377e-01 | 0.437 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.444247e-01 | 0.463 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.444247e-01 | 0.463 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.132922e-01 | 0.671 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.949137e-01 | 0.530 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.692779e-01 | 0.570 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.579321e-01 | 0.588 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.375248e-01 | 0.624 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.765018e-01 | 0.558 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.891877e-01 | 0.539 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.891877e-01 | 0.539 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.030029e-01 | 0.519 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.350283e-01 | 0.475 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.350283e-01 | 0.475 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.758739e-01 | 0.425 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.758739e-01 | 0.425 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.017990e-01 | 0.396 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.017990e-01 | 0.396 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.825615e-01 | 0.549 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.825615e-01 | 0.549 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.954656e-01 | 0.529 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.248236e-01 | 0.488 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.417714e-01 | 0.466 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.132999e-01 | 0.671 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.607231e-01 | 0.443 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.607231e-01 | 0.443 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.607231e-01 | 0.443 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.686849e-01 | 0.571 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.469311e-01 | 0.460 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.469311e-01 | 0.460 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.469311e-01 | 0.460 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.365866e-01 | 0.626 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.509657e-01 | 0.455 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.509657e-01 | 0.455 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.121009e-01 | 0.506 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.895670e-01 | 0.409 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.431139e-01 | 0.465 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.916910e-01 | 0.407 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.991073e-01 | 0.524 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.991073e-01 | 0.524 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.955365e-01 | 0.529 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.652159e-01 | 0.437 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.430117e-01 | 0.465 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.128710e-01 | 0.384 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.132999e-01 | 0.671 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.607231e-01 | 0.443 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.777133e-01 | 0.556 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.901508e-01 | 0.537 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.954436e-01 | 0.403 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.777133e-01 | 0.556 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.770814e-01 | 0.424 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.483612e-01 | 0.458 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.607231e-01 | 0.443 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.350283e-01 | 0.475 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.540211e-01 | 0.451 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.787988e-01 | 0.422 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.105136e-01 | 0.387 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.822974e-01 | 0.549 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.139601e-01 | 0.670 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.939141e-01 | 0.532 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.605397e-01 | 0.584 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.444247e-01 | 0.463 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.605397e-01 | 0.584 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.107614e-01 | 0.508 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.124948e-01 | 0.673 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.498178e-01 | 0.602 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.148863e-01 | 0.502 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.579321e-01 | 0.588 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.605397e-01 | 0.584 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.468053e-01 | 0.460 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.871821e-01 | 0.542 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.798568e-01 | 0.420 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.107614e-01 | 0.508 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.048008e-01 | 0.516 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.483612e-01 | 0.458 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.658377e-01 | 0.437 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.949137e-01 | 0.530 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.072961e-01 | 0.390 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.800226e-01 | 0.420 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.509657e-01 | 0.455 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.308701e-01 | 0.637 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.407174e-01 | 0.468 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.141893e-01 | 0.383 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.840276e-01 | 0.416 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.468053e-01 | 0.460 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.101666e-01 | 0.387 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.375248e-01 | 0.624 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.190880e-01 | 0.659 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.822614e-01 | 0.418 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.822614e-01 | 0.418 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.429899e-01 | 0.465 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.949137e-01 | 0.530 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.915331e-01 | 0.535 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.618936e-01 | 0.441 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.416463e-01 | 0.617 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.213075e-01 | 0.655 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.428207e-01 | 0.465 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.688420e-01 | 0.433 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.822974e-01 | 0.549 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.201670e-01 | 0.657 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.258875e-01 | 0.487 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.899632e-01 | 0.409 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.206722e-01 | 0.376 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.513806e-01 | 0.600 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.520780e-01 | 0.598 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.194094e-01 | 0.496 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.513806e-01 | 0.600 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.644022e-01 | 0.438 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.094828e-01 | 0.509 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.949807e-01 | 0.403 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.048008e-01 | 0.516 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.688420e-01 | 0.433 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.934057e-01 | 0.405 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.185275e-01 | 0.660 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.469311e-01 | 0.460 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.655999e-01 | 0.437 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.934057e-01 | 0.405 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.443131e-01 | 0.612 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.297707e-01 | 0.482 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.072961e-01 | 0.390 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.618296e-01 | 0.582 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.356480e-01 | 0.474 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.201670e-01 | 0.657 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.949137e-01 | 0.530 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.113737e-01 | 0.675 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.221848e-01 | 0.653 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.758739e-01 | 0.425 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 3.658377e-01 | 0.437 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.451200e-01 | 0.462 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.132922e-01 | 0.671 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.228000e-01 | 0.491 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.516535e-01 | 0.599 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.516535e-01 | 0.599 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.830309e-01 | 0.417 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.830309e-01 | 0.417 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.830309e-01 | 0.417 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.830309e-01 | 0.417 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.830309e-01 | 0.417 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.830309e-01 | 0.417 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.048008e-01 | 0.516 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.048008e-01 | 0.516 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 3.688420e-01 | 0.433 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.688420e-01 | 0.433 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.520780e-01 | 0.598 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.916219e-01 | 0.407 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.444247e-01 | 0.463 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.051153e-01 | 0.516 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.509657e-01 | 0.455 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.588253e-01 | 0.445 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.109010e-01 | 0.386 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.143855e-01 | 0.383 | 1 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.986393e-01 | 0.399 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.124948e-01 | 0.673 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.280185e-01 | 0.642 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.509657e-01 | 0.455 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.051153e-01 | 0.516 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.981900e-01 | 0.526 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.956334e-01 | 0.403 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.436883e-01 | 0.613 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.094828e-01 | 0.509 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.407174e-01 | 0.468 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.614991e-01 | 0.583 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.865674e-01 | 0.413 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.770814e-01 | 0.424 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.765018e-01 | 0.558 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.605397e-01 | 0.584 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.579321e-01 | 0.588 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.395764e-01 | 0.621 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.541673e-01 | 0.451 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.350283e-01 | 0.475 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.144358e-01 | 0.383 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.647735e-01 | 0.577 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.483612e-01 | 0.458 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.800049e-01 | 0.553 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.709614e-01 | 0.567 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.830309e-01 | 0.417 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.830309e-01 | 0.417 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.107614e-01 | 0.508 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.688420e-01 | 0.433 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.520780e-01 | 0.598 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.720802e-01 | 0.565 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.148863e-01 | 0.502 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.144224e-01 | 0.383 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.509657e-01 | 0.455 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.939141e-01 | 0.532 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.297707e-01 | 0.482 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.600618e-01 | 0.585 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.483612e-01 | 0.458 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.259442e-01 | 0.487 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.072961e-01 | 0.390 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.525396e-01 | 0.453 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.586152e-01 | 0.587 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.586152e-01 | 0.587 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.498178e-01 | 0.602 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.741563e-01 | 0.427 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.444247e-01 | 0.463 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.072961e-01 | 0.390 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.916219e-01 | 0.407 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.714593e-01 | 0.566 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.520780e-01 | 0.598 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.017990e-01 | 0.396 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.248944e-01 | 0.372 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.248944e-01 | 0.372 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.248944e-01 | 0.372 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.248944e-01 | 0.372 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.248944e-01 | 0.372 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.287905e-01 | 0.368 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.337434e-01 | 0.363 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.341141e-01 | 0.362 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.341141e-01 | 0.362 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.341141e-01 | 0.362 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.341141e-01 | 0.362 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.343564e-01 | 0.362 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.343564e-01 | 0.362 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.373724e-01 | 0.359 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 4.373724e-01 | 0.359 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.373724e-01 | 0.359 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.382448e-01 | 0.358 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.384983e-01 | 0.358 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.384983e-01 | 0.358 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.386351e-01 | 0.358 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.386351e-01 | 0.358 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.386351e-01 | 0.358 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.386351e-01 | 0.358 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.386351e-01 | 0.358 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.419816e-01 | 0.355 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.430337e-01 | 0.354 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.507538e-01 | 0.346 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.575216e-01 | 0.340 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.590551e-01 | 0.338 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.590551e-01 | 0.338 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.641443e-01 | 0.333 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.664941e-01 | 0.331 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.664941e-01 | 0.331 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.664941e-01 | 0.331 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.682383e-01 | 0.330 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.682383e-01 | 0.330 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.687491e-01 | 0.329 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.687491e-01 | 0.329 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.687491e-01 | 0.329 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.693056e-01 | 0.329 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.693056e-01 | 0.329 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.693056e-01 | 0.329 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.693056e-01 | 0.329 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.723111e-01 | 0.326 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.747785e-01 | 0.324 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 4.747785e-01 | 0.324 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.747785e-01 | 0.324 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.747785e-01 | 0.324 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.747785e-01 | 0.324 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.747785e-01 | 0.324 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.747785e-01 | 0.324 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.747785e-01 | 0.324 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.747785e-01 | 0.324 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.747785e-01 | 0.324 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.747785e-01 | 0.324 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.747785e-01 | 0.324 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.747785e-01 | 0.324 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.747785e-01 | 0.324 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.747785e-01 | 0.324 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.747785e-01 | 0.324 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.754548e-01 | 0.323 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.754548e-01 | 0.323 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.754548e-01 | 0.323 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 4.782378e-01 | 0.320 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.782378e-01 | 0.320 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.782378e-01 | 0.320 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.782378e-01 | 0.320 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.782378e-01 | 0.320 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.782378e-01 | 0.320 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.782378e-01 | 0.320 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.782378e-01 | 0.320 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.782378e-01 | 0.320 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.782378e-01 | 0.320 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 4.782378e-01 | 0.320 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.782378e-01 | 0.320 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.850255e-01 | 0.314 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.861969e-01 | 0.313 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.884840e-01 | 0.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.892043e-01 | 0.311 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.892043e-01 | 0.311 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.939700e-01 | 0.306 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.939700e-01 | 0.306 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.939700e-01 | 0.306 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.945598e-01 | 0.306 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.980711e-01 | 0.303 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.987567e-01 | 0.302 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.995622e-01 | 0.301 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.995622e-01 | 0.301 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.995622e-01 | 0.301 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.995622e-01 | 0.301 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.997709e-01 | 0.301 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.032942e-01 | 0.298 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.032942e-01 | 0.298 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.043518e-01 | 0.297 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.064037e-01 | 0.296 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.064037e-01 | 0.296 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.064037e-01 | 0.296 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.083782e-01 | 0.294 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.097743e-01 | 0.293 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.153403e-01 | 0.288 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.153403e-01 | 0.288 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 5.153403e-01 | 0.288 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.153403e-01 | 0.288 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.153403e-01 | 0.288 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.153403e-01 | 0.288 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.168190e-01 | 0.287 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.190527e-01 | 0.285 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.191407e-01 | 0.285 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.209542e-01 | 0.283 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.209542e-01 | 0.283 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.235648e-01 | 0.281 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.271219e-01 | 0.278 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.284384e-01 | 0.277 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.284384e-01 | 0.277 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.284384e-01 | 0.277 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.284384e-01 | 0.277 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.284384e-01 | 0.277 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 5.284384e-01 | 0.277 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.284384e-01 | 0.277 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.291316e-01 | 0.276 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.291316e-01 | 0.276 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.291316e-01 | 0.276 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.385725e-01 | 0.269 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.387049e-01 | 0.269 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.387049e-01 | 0.269 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.387049e-01 | 0.269 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.394737e-01 | 0.268 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.394737e-01 | 0.268 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.394737e-01 | 0.268 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.473502e-01 | 0.262 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.528870e-01 | 0.257 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.528870e-01 | 0.257 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 5.528870e-01 | 0.257 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 5.528870e-01 | 0.257 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.528870e-01 | 0.257 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 5.528870e-01 | 0.257 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.528870e-01 | 0.257 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.528870e-01 | 0.257 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.528870e-01 | 0.257 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.530428e-01 | 0.257 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.535392e-01 | 0.257 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.535392e-01 | 0.257 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.578965e-01 | 0.253 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.578965e-01 | 0.253 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.611926e-01 | 0.251 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.674312e-01 | 0.246 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.700227e-01 | 0.244 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.700227e-01 | 0.244 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.713775e-01 | 0.243 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.713775e-01 | 0.243 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.719461e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.719461e-01 | 0.243 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.719461e-01 | 0.243 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.752514e-01 | 0.240 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.752514e-01 | 0.240 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.752514e-01 | 0.240 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.752514e-01 | 0.240 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.752514e-01 | 0.240 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.752514e-01 | 0.240 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.752514e-01 | 0.240 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.752514e-01 | 0.240 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.830377e-01 | 0.234 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.857583e-01 | 0.232 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.857583e-01 | 0.232 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.894915e-01 | 0.230 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.898837e-01 | 0.229 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.898837e-01 | 0.229 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.932788e-01 | 0.227 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.980531e-01 | 0.223 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.980531e-01 | 0.223 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.007621e-01 | 0.221 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.017940e-01 | 0.221 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.020022e-01 | 0.220 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.020022e-01 | 0.220 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.020022e-01 | 0.220 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.020022e-01 | 0.220 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.089222e-01 | 0.215 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.126365e-01 | 0.213 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.185741e-01 | 0.209 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.185741e-01 | 0.209 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.185741e-01 | 0.209 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.185741e-01 | 0.209 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.185741e-01 | 0.209 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.185741e-01 | 0.209 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.185741e-01 | 0.209 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.193834e-01 | 0.208 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.193834e-01 | 0.208 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.193834e-01 | 0.208 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 6.193834e-01 | 0.208 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 6.193834e-01 | 0.208 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 6.193834e-01 | 0.208 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.193834e-01 | 0.208 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.201118e-01 | 0.208 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.235295e-01 | 0.205 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.242616e-01 | 0.205 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.242616e-01 | 0.205 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.242616e-01 | 0.205 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.242616e-01 | 0.205 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.310228e-01 | 0.200 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.310228e-01 | 0.200 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.310228e-01 | 0.200 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.312633e-01 | 0.200 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.360795e-01 | 0.196 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.384675e-01 | 0.195 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.384675e-01 | 0.195 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.455477e-01 | 0.190 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.455477e-01 | 0.190 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.459742e-01 | 0.190 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.460458e-01 | 0.190 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.560897e-01 | 0.183 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.560897e-01 | 0.183 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.560897e-01 | 0.183 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.566080e-01 | 0.183 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.566080e-01 | 0.183 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.566080e-01 | 0.183 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.566497e-01 | 0.183 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.566538e-01 | 0.183 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.584091e-01 | 0.182 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.584091e-01 | 0.182 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.584091e-01 | 0.182 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 6.584091e-01 | 0.182 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.584091e-01 | 0.182 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.584091e-01 | 0.182 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.591021e-01 | 0.181 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.591021e-01 | 0.181 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.591021e-01 | 0.181 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.632035e-01 | 0.178 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.653629e-01 | 0.177 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.714161e-01 | 0.173 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.714161e-01 | 0.173 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.730196e-01 | 0.172 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.730196e-01 | 0.172 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.730196e-01 | 0.172 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.730196e-01 | 0.172 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.730196e-01 | 0.172 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.759934e-01 | 0.170 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.759934e-01 | 0.170 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.759934e-01 | 0.170 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.759934e-01 | 0.170 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.759934e-01 | 0.170 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.759934e-01 | 0.170 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.759934e-01 | 0.170 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.759934e-01 | 0.170 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.759934e-01 | 0.170 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.759934e-01 | 0.170 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.759934e-01 | 0.170 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.759934e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.759934e-01 | 0.170 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.781465e-01 | 0.169 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.793435e-01 | 0.168 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.854824e-01 | 0.164 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.868979e-01 | 0.163 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.868979e-01 | 0.163 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.868979e-01 | 0.163 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.868979e-01 | 0.163 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.868979e-01 | 0.163 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.868979e-01 | 0.163 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.883066e-01 | 0.162 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.894818e-01 | 0.161 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.894818e-01 | 0.161 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.948356e-01 | 0.158 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.948356e-01 | 0.158 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.948356e-01 | 0.158 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 6.948356e-01 | 0.158 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.948356e-01 | 0.158 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.948356e-01 | 0.158 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.948356e-01 | 0.158 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.948356e-01 | 0.158 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.948356e-01 | 0.158 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.966230e-01 | 0.157 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.013287e-01 | 0.154 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.035765e-01 | 0.153 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.046576e-01 | 0.152 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.119038e-01 | 0.148 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.119707e-01 | 0.148 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.144067e-01 | 0.146 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.151391e-01 | 0.146 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.151391e-01 | 0.146 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.151391e-01 | 0.146 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.151391e-01 | 0.146 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.151391e-01 | 0.146 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.151391e-01 | 0.146 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.163213e-01 | 0.145 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.204575e-01 | 0.142 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.241865e-01 | 0.140 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.241865e-01 | 0.140 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.241865e-01 | 0.140 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.241865e-01 | 0.140 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.241865e-01 | 0.140 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.241865e-01 | 0.140 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.241865e-01 | 0.140 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 7.241865e-01 | 0.140 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 7.241865e-01 | 0.140 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.241865e-01 | 0.140 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.241865e-01 | 0.140 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.241865e-01 | 0.140 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 7.241865e-01 | 0.140 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.241865e-01 | 0.140 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 7.241865e-01 | 0.140 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.241865e-01 | 0.140 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 7.241865e-01 | 0.140 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 7.241865e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 7.241865e-01 | 0.140 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 7.241865e-01 | 0.140 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.241865e-01 | 0.140 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.260092e-01 | 0.139 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.279861e-01 | 0.138 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.279861e-01 | 0.138 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.279861e-01 | 0.138 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.279861e-01 | 0.138 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.279861e-01 | 0.138 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.279861e-01 | 0.138 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.279861e-01 | 0.138 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.305723e-01 | 0.136 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.305723e-01 | 0.136 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.319383e-01 | 0.136 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.320615e-01 | 0.135 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.326422e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.338205e-01 | 0.134 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.340332e-01 | 0.134 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.349684e-01 | 0.134 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.405675e-01 | 0.130 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.413659e-01 | 0.130 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.413659e-01 | 0.130 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.413659e-01 | 0.130 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.475602e-01 | 0.126 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.483212e-01 | 0.126 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.483212e-01 | 0.126 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.488695e-01 | 0.126 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.507194e-01 | 0.125 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.507194e-01 | 0.125 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.507194e-01 | 0.125 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.526532e-01 | 0.123 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.530634e-01 | 0.123 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.557954e-01 | 0.122 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.557954e-01 | 0.122 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.557954e-01 | 0.122 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.580291e-01 | 0.120 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.580291e-01 | 0.120 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.580291e-01 | 0.120 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.580291e-01 | 0.120 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.580291e-01 | 0.120 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.590008e-01 | 0.120 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.606787e-01 | 0.119 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.607975e-01 | 0.119 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.637047e-01 | 0.117 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.640439e-01 | 0.117 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.640439e-01 | 0.117 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.641679e-01 | 0.117 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.644811e-01 | 0.117 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.652136e-01 | 0.116 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.652136e-01 | 0.116 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 7.652136e-01 | 0.116 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.652136e-01 | 0.116 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.652136e-01 | 0.116 | 0 | 0 |
| Agmatine biosynthesis | R-HSA-351143 | 7.652136e-01 | 0.116 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.652136e-01 | 0.116 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.652136e-01 | 0.116 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.652136e-01 | 0.116 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 7.652136e-01 | 0.116 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.652136e-01 | 0.116 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.652136e-01 | 0.116 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.656336e-01 | 0.116 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.660290e-01 | 0.116 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.660290e-01 | 0.116 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.697226e-01 | 0.114 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.752730e-01 | 0.111 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.753069e-01 | 0.111 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.763410e-01 | 0.110 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.763410e-01 | 0.110 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.763410e-01 | 0.110 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.787198e-01 | 0.109 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.795673e-01 | 0.108 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.827950e-01 | 0.106 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.827950e-01 | 0.106 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.851555e-01 | 0.105 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.851555e-01 | 0.105 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.851555e-01 | 0.105 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.851555e-01 | 0.105 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.851555e-01 | 0.105 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.851555e-01 | 0.105 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.851555e-01 | 0.105 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.876007e-01 | 0.104 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.880134e-01 | 0.103 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.927197e-01 | 0.101 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.954955e-01 | 0.099 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.954955e-01 | 0.099 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.954955e-01 | 0.099 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.960737e-01 | 0.099 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.986338e-01 | 0.098 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.986338e-01 | 0.098 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.001400e-01 | 0.097 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 8.001400e-01 | 0.097 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 8.001400e-01 | 0.097 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 8.001400e-01 | 0.097 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.001400e-01 | 0.097 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 8.001400e-01 | 0.097 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.001400e-01 | 0.097 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 8.001400e-01 | 0.097 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 8.001400e-01 | 0.097 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 8.001400e-01 | 0.097 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 8.001400e-01 | 0.097 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.001400e-01 | 0.097 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.001400e-01 | 0.097 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.001400e-01 | 0.097 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 8.001400e-01 | 0.097 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 8.001400e-01 | 0.097 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 8.001400e-01 | 0.097 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.018753e-01 | 0.096 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.034082e-01 | 0.095 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.085886e-01 | 0.092 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.085886e-01 | 0.092 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.095681e-01 | 0.092 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.095681e-01 | 0.092 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.095681e-01 | 0.092 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.095681e-01 | 0.092 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.095681e-01 | 0.092 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.095681e-01 | 0.092 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.095681e-01 | 0.092 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.095681e-01 | 0.092 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.095681e-01 | 0.092 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.101589e-01 | 0.091 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.133053e-01 | 0.090 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.133053e-01 | 0.090 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.135647e-01 | 0.090 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.135647e-01 | 0.090 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.139985e-01 | 0.089 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.176470e-01 | 0.087 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.180913e-01 | 0.087 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.191447e-01 | 0.087 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.191447e-01 | 0.087 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.252915e-01 | 0.083 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.274506e-01 | 0.082 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.276111e-01 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.298229e-01 | 0.081 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.298229e-01 | 0.081 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.298724e-01 | 0.081 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 8.298724e-01 | 0.081 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.298724e-01 | 0.081 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.298724e-01 | 0.081 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 8.298724e-01 | 0.081 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 8.298724e-01 | 0.081 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.298724e-01 | 0.081 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.298724e-01 | 0.081 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.298724e-01 | 0.081 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.298724e-01 | 0.081 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.298724e-01 | 0.081 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.298724e-01 | 0.081 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.314739e-01 | 0.080 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.314739e-01 | 0.080 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.314739e-01 | 0.080 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.314739e-01 | 0.080 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.336034e-01 | 0.079 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.347653e-01 | 0.078 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.347653e-01 | 0.078 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.347653e-01 | 0.078 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.347992e-01 | 0.078 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.353017e-01 | 0.078 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.407993e-01 | 0.075 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.446961e-01 | 0.073 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.446961e-01 | 0.073 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.446961e-01 | 0.073 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.451054e-01 | 0.073 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.451054e-01 | 0.073 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.461336e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.476009e-01 | 0.072 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.510784e-01 | 0.070 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.510784e-01 | 0.070 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.529485e-01 | 0.069 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.531582e-01 | 0.069 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.534314e-01 | 0.069 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.538060e-01 | 0.069 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.541399e-01 | 0.068 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.551832e-01 | 0.068 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.551832e-01 | 0.068 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.551832e-01 | 0.068 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 8.551832e-01 | 0.068 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.551832e-01 | 0.068 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 8.551832e-01 | 0.068 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.551832e-01 | 0.068 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.551832e-01 | 0.068 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.589744e-01 | 0.066 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.592132e-01 | 0.066 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.595022e-01 | 0.066 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.604248e-01 | 0.065 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.604248e-01 | 0.065 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.604248e-01 | 0.065 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.640989e-01 | 0.063 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.647189e-01 | 0.063 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.676408e-01 | 0.062 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.685812e-01 | 0.061 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.722087e-01 | 0.059 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.722087e-01 | 0.059 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.737994e-01 | 0.059 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.747368e-01 | 0.058 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.747368e-01 | 0.058 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.747368e-01 | 0.058 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.747368e-01 | 0.058 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.767295e-01 | 0.057 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.767295e-01 | 0.057 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 8.767295e-01 | 0.057 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.767295e-01 | 0.057 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.767295e-01 | 0.057 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.767295e-01 | 0.057 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.767295e-01 | 0.057 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.767295e-01 | 0.057 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.767295e-01 | 0.057 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.767295e-01 | 0.057 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.785543e-01 | 0.056 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.786900e-01 | 0.056 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.789679e-01 | 0.056 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.841553e-01 | 0.053 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.841553e-01 | 0.053 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.841553e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.841738e-01 | 0.053 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.841738e-01 | 0.053 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.841738e-01 | 0.053 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.841738e-01 | 0.053 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.841738e-01 | 0.053 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.860564e-01 | 0.053 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.868003e-01 | 0.052 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.877317e-01 | 0.052 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.900942e-01 | 0.051 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.950712e-01 | 0.048 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.950712e-01 | 0.048 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.950712e-01 | 0.048 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.950712e-01 | 0.048 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.950712e-01 | 0.048 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.950712e-01 | 0.048 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.950712e-01 | 0.048 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.950712e-01 | 0.048 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.950712e-01 | 0.048 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.950712e-01 | 0.048 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.950712e-01 | 0.048 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.951163e-01 | 0.048 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.951163e-01 | 0.048 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.966766e-01 | 0.047 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.980370e-01 | 0.047 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.980370e-01 | 0.047 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.980370e-01 | 0.047 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.980370e-01 | 0.047 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.995069e-01 | 0.046 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.995069e-01 | 0.046 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.995069e-01 | 0.046 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.995069e-01 | 0.046 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.025418e-01 | 0.045 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.051547e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.051547e-01 | 0.043 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.051547e-01 | 0.043 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.101563e-01 | 0.041 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.102269e-01 | 0.041 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.103401e-01 | 0.041 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.103401e-01 | 0.041 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.103401e-01 | 0.041 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.103401e-01 | 0.041 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.103401e-01 | 0.041 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.103401e-01 | 0.041 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.103401e-01 | 0.041 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.103401e-01 | 0.041 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 9.106847e-01 | 0.041 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 9.106847e-01 | 0.041 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 9.106847e-01 | 0.041 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 9.106847e-01 | 0.041 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 9.106847e-01 | 0.041 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.106847e-01 | 0.041 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 9.106847e-01 | 0.041 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.106847e-01 | 0.041 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 9.106847e-01 | 0.041 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 9.106847e-01 | 0.041 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.133702e-01 | 0.039 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.158139e-01 | 0.038 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.161495e-01 | 0.038 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.182109e-01 | 0.037 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.197705e-01 | 0.036 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.197705e-01 | 0.036 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.212404e-01 | 0.036 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.212404e-01 | 0.036 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.212404e-01 | 0.036 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.227079e-01 | 0.035 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.227079e-01 | 0.035 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.239756e-01 | 0.034 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.239756e-01 | 0.034 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 9.239756e-01 | 0.034 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.239756e-01 | 0.034 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.239756e-01 | 0.034 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.239756e-01 | 0.034 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.239756e-01 | 0.034 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.239756e-01 | 0.034 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.260861e-01 | 0.033 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.281028e-01 | 0.032 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.284354e-01 | 0.032 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.284354e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.303404e-01 | 0.031 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.303404e-01 | 0.031 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.303404e-01 | 0.031 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.303404e-01 | 0.031 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.308829e-01 | 0.031 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.308829e-01 | 0.031 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.308829e-01 | 0.031 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.325107e-01 | 0.030 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 9.352894e-01 | 0.029 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.352894e-01 | 0.029 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 9.352894e-01 | 0.029 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 9.352894e-01 | 0.029 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.352894e-01 | 0.029 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.352894e-01 | 0.029 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.352894e-01 | 0.029 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.352894e-01 | 0.029 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.363814e-01 | 0.029 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.372848e-01 | 0.028 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.377896e-01 | 0.028 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.394004e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.394004e-01 | 0.027 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.394004e-01 | 0.027 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.394004e-01 | 0.027 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.394004e-01 | 0.027 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.432374e-01 | 0.025 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.449200e-01 | 0.025 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.449200e-01 | 0.025 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.449200e-01 | 0.025 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.449200e-01 | 0.025 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.449200e-01 | 0.025 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.449200e-01 | 0.025 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.449200e-01 | 0.025 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.449200e-01 | 0.025 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.449200e-01 | 0.025 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.449200e-01 | 0.025 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.449200e-01 | 0.025 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.449200e-01 | 0.025 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.457978e-01 | 0.024 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.457978e-01 | 0.024 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.463870e-01 | 0.024 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.469142e-01 | 0.024 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.469142e-01 | 0.024 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.469142e-01 | 0.024 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.493177e-01 | 0.023 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.495222e-01 | 0.022 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.529064e-01 | 0.021 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.531178e-01 | 0.021 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.531178e-01 | 0.021 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.531178e-01 | 0.021 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.531178e-01 | 0.021 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.531178e-01 | 0.021 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.531178e-01 | 0.021 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.531178e-01 | 0.021 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.531178e-01 | 0.021 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.531178e-01 | 0.021 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.531178e-01 | 0.021 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.531178e-01 | 0.021 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.534408e-01 | 0.021 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.535343e-01 | 0.021 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.535343e-01 | 0.021 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.535343e-01 | 0.021 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.536840e-01 | 0.021 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.551530e-01 | 0.020 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.557729e-01 | 0.020 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.576609e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.576609e-01 | 0.019 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.591964e-01 | 0.018 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.593603e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.593603e-01 | 0.018 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.595246e-01 | 0.018 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.600959e-01 | 0.018 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.600959e-01 | 0.018 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.600959e-01 | 0.018 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.600959e-01 | 0.018 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.600959e-01 | 0.018 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.600959e-01 | 0.018 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.600959e-01 | 0.018 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.601915e-01 | 0.018 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.601915e-01 | 0.018 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.601915e-01 | 0.018 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.608171e-01 | 0.017 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.609540e-01 | 0.017 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.615308e-01 | 0.017 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.625533e-01 | 0.017 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.630228e-01 | 0.016 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.630228e-01 | 0.016 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.638123e-01 | 0.016 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.644818e-01 | 0.016 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.646944e-01 | 0.016 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.650757e-01 | 0.015 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 9.660357e-01 | 0.015 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.660357e-01 | 0.015 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.660357e-01 | 0.015 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.660357e-01 | 0.015 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.660357e-01 | 0.015 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.660357e-01 | 0.015 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.660357e-01 | 0.015 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.660357e-01 | 0.015 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.660357e-01 | 0.015 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.660357e-01 | 0.015 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.660357e-01 | 0.015 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.660357e-01 | 0.015 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.672657e-01 | 0.014 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.672657e-01 | 0.014 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.674795e-01 | 0.014 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.689795e-01 | 0.014 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.697581e-01 | 0.013 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.707174e-01 | 0.013 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.710916e-01 | 0.013 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.710916e-01 | 0.013 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.710916e-01 | 0.013 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.710916e-01 | 0.013 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.710916e-01 | 0.013 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.710916e-01 | 0.013 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.710916e-01 | 0.013 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.711060e-01 | 0.013 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.726079e-01 | 0.012 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.729255e-01 | 0.012 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.738262e-01 | 0.012 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.738262e-01 | 0.012 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.739916e-01 | 0.011 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.753952e-01 | 0.011 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.753952e-01 | 0.011 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.753952e-01 | 0.011 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.753952e-01 | 0.011 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.761616e-01 | 0.010 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.763844e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.766233e-01 | 0.010 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.775274e-01 | 0.010 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.788364e-01 | 0.009 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.790583e-01 | 0.009 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.790583e-01 | 0.009 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.790583e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.790583e-01 | 0.009 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.790583e-01 | 0.009 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.790583e-01 | 0.009 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.790583e-01 | 0.009 | 0 | 0 |
| Transport of nucleotide sugars | R-HSA-727802 | 9.790583e-01 | 0.009 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.790583e-01 | 0.009 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.794138e-01 | 0.009 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.794138e-01 | 0.009 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.807409e-01 | 0.008 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.820648e-01 | 0.008 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.820648e-01 | 0.008 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.821762e-01 | 0.008 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.821762e-01 | 0.008 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.821762e-01 | 0.008 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.821762e-01 | 0.008 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.821762e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.827916e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.827916e-01 | 0.008 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.830977e-01 | 0.007 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.844852e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.845415e-01 | 0.007 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.848301e-01 | 0.007 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.848301e-01 | 0.007 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.848301e-01 | 0.007 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.848301e-01 | 0.007 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.848301e-01 | 0.007 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.850873e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.850873e-01 | 0.007 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.850873e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.856416e-01 | 0.006 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.860708e-01 | 0.006 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.861841e-01 | 0.006 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.864085e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.866731e-01 | 0.006 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.868512e-01 | 0.006 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.870429e-01 | 0.006 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.870889e-01 | 0.006 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.870889e-01 | 0.006 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.872549e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.881773e-01 | 0.005 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.881773e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.881773e-01 | 0.005 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.881773e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.886121e-01 | 0.005 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.890115e-01 | 0.005 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.890115e-01 | 0.005 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.890115e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.890115e-01 | 0.005 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.890115e-01 | 0.005 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.890115e-01 | 0.005 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.890115e-01 | 0.005 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.890115e-01 | 0.005 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.896113e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.896670e-01 | 0.005 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.897208e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.897208e-01 | 0.004 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.897208e-01 | 0.004 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.904779e-01 | 0.004 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.906479e-01 | 0.004 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.906479e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.909634e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.910195e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.910669e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.912953e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.913995e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.916432e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.916855e-01 | 0.004 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.920407e-01 | 0.003 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.920407e-01 | 0.003 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.920407e-01 | 0.003 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.920407e-01 | 0.003 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.920407e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.920407e-01 | 0.003 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.921004e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.922401e-01 | 0.003 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.928690e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.930440e-01 | 0.003 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.930550e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.930906e-01 | 0.003 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.932262e-01 | 0.003 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.932262e-01 | 0.003 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.932262e-01 | 0.003 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.932262e-01 | 0.003 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.932262e-01 | 0.003 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.932262e-01 | 0.003 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.932262e-01 | 0.003 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.932262e-01 | 0.003 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.932262e-01 | 0.003 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.932262e-01 | 0.003 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.932575e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.932621e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.932621e-01 | 0.003 | 0 | 0 |
| Translation | R-HSA-72766 | 9.933581e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.936340e-01 | 0.003 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.941519e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.941519e-01 | 0.003 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.942351e-01 | 0.003 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.942351e-01 | 0.003 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.942351e-01 | 0.003 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.942351e-01 | 0.003 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.942351e-01 | 0.003 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.942351e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.942902e-01 | 0.002 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.947220e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.949262e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.949352e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.949428e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.950938e-01 | 0.002 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.950938e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.950938e-01 | 0.002 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.950938e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.950938e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.950938e-01 | 0.002 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.950938e-01 | 0.002 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.952953e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.952953e-01 | 0.002 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.955996e-01 | 0.002 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.955996e-01 | 0.002 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.958246e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NTPDase proteins | R-HSA-8850843 | 9.958246e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.958721e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.963277e-01 | 0.002 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.964466e-01 | 0.002 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.964466e-01 | 0.002 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.964466e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.968267e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.969045e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.971356e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.971356e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.971356e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.974266e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.975192e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.975192e-01 | 0.001 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.978100e-01 | 0.001 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.978100e-01 | 0.001 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.978100e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.978521e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.978680e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.980075e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.980124e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.981344e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.981363e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.981648e-01 | 0.001 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.984140e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.985730e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.986504e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.986504e-01 | 0.001 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.986504e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.987966e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.988377e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.989102e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.990100e-01 | 0.000 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.990227e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.990227e-01 | 0.000 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.990227e-01 | 0.000 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.990227e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.990602e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.992079e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.992229e-01 | 0.000 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.993978e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.994478e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.994745e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.994876e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.994876e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.994935e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.995186e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995384e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.995640e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.995677e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.996014e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.996269e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.996290e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.996780e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997224e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997583e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.997714e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.997714e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.997896e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.997933e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998371e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998501e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998676e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.998716e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.998802e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.998981e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.998981e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999049e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.999133e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.999262e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.999262e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999270e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999444e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.999466e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999527e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999596e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999599e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999599e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999613e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999630e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999639e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999655e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999671e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999671e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999674e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999674e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999704e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999744e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999744e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999797e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999853e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999860e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999894e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999907e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999910e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999911e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999937e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999944e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999945e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999947e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999964e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999985e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999989e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999989e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999994e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999996e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999997e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999998e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 1.000000e+00 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |